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Preface
The respiratory system, as a port of entry, plays an important role in the health and 
disease of individuals. Understanding respiratory physiology can aid practitioners 
in diagnosing the cause of respiratory symptoms. Physiological factors should 
be considered before interpreting any medical condition. Clinical application of 
physiology knowledge can influence the outcome of respiratory disorders.
This book is for medical students, residents, healthcare workers, and scientists. 
Understanding of the concepts contained in this book will give confidence to 
provide effective medical care.
Chapters cover aspects of hyperbaric physiology, exercise physiology, skeletal 
muscle dysfunction in chronic respiratory disease patients, impact of environmental 
media on the respiratory system, and cognitive impairment in chronic respiratory 
patients.
Respiratory Physiology is organized into three sections containing five chapters. 
Section 1 contains an introductory chapter that discusses the general principles of 
physiology. Section 2 examines respiratory physiology and exercise. It covers the 
principles of intermittent sprint work as well as the indicators of sarcopenia 
in patients with chronic respiratory disease. Section 3 describes the impact of 
environmental media on the respiratory system.
Sections 2 and 3 provides interesting information about exercise, altitude, and 
environmental pollution and their impact on health and disease.
As the knowledge of physiology is constantly increasing, this book includes 
interesting concepts and evidence based on experiences from clinical trials.
I thank all the authors for their contributions in making this interesting manuscript. 
I hope readers will enjoy this study of physiology and deepen their knowledge of 
this field.
Ketevan Nemsadze
David Tvildiani Medical University,
Georgia
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Introductory Chapter: Respiratory 
Physiology
Ketevan Nemsadze
1. Introduction: What is physiology?
Physiology is the link between the basic sciences and medicine. It integrates the 
individual functions of all the body’s different cells, tissues, and organs into a func-
tional whole, the human body. Understanding the principles of physiology can help 
us explain the physical and chemical mechanisms that are responsible for the origin, 
development, and progression of life. Each type of life is from the simplest virus to the 
largest tree or the complicated human being. The science of human physiology attempts 
to explain the specific characteristics and mechanisms of the human body that make 
it a living being. The fact that we remain alive is the result of complex control systems. 
Ultimately, the functions of cells, tissues, and organs must be coordinated and regu-
lated. All of these functions are the essence of the discipline of physiology [1, 2].
Physiology studies dynamic processes of life from the simplest molecules, 
organelles, cells, tissues to the complex organs and organ systems. The discipline of 
physiology has been closely interconnected with medicine. Structure and function 
are related to each other – as in case of anatomy, histology, structural biology and 
physiology [3].
Medical physiology deals with how the human body functions. Countless 
molecules, subcellular organelles, cells, tissues, organs and organ systems work 
coordinately to maintain the homeostasis of a body. It is essential to take a global 
view of the human body, considering every level of the organizational unit.
Classification of physiology could be according to the organ systems. For many 
practicing clinicians, physiology may be the function of an individual organ system, 
such as the cardiovascular, respiratory, or gastrointestinal system. Others focus on 
the cellular principles that are common to the function of all organs and tissues. 
This last field has traditionally been called general physiology, but nowadays the 
term of cellular and molecular physiology.
As a discipline of physiology evolves and new information emerges, there is a 
tendency to integrate physiological concepts from the level of DNA and epigenetics 
to the human body, and everything in between [4].
Physiological genomics is the link between the organ and the gene. The grand 
organizer—the master that controls the molecules, the cells, and the organs and the 
way they interact—is the genome with its epigenetic modifications. Physiological 
genomics (or functional genomics) is a new branch of physiology devoted to the 
understanding of the roles that genes play in physiology [3].
Some important aspects of physiology remain as fundamentally important today 
as when the pioneers of physiology discovered them a century or more ago. These 
early observations were generally phenomenological descriptions that physiologists 
have since been trying to understand at a mechanistic level. In his lectures on the 
phenomena of life, Claude Bernard noted in 1878 on the conditions of the constancy 
of life. Claude Bernard introduced the concept of “milieu intérieur” – internal 
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environment. He stated that animals have two environments: the “milieu extérieur” 
that physically surrounds the whole organism and the “milieu intérieur,” in which 
the tissues and cells of the organism live. The internal environment surrounds 
and bathes all the anatomic elements of the tissues, the lymph or the plasma. This 
internal environment is what we today call the extracellular fluid.
Another theme developed by Bernard was that the “fixité du milieu intérieur” 
(the constancy of the extracellular fluid) is the condition of “free, independent 
life.” Homeostatic mechanisms—operating through sophisticated feedback control 
mechanisms—are responsible for maintaining the constancy of the milieu intérieur. 
Homeostasis is defined as a self-regulating process by which an organism maintains 
internal stability in a constantly changing external condition. Homeostasis regulates 
the processes in the body in the way that returns critical systems of the body to a set 
point that is necessary for the organism to survive [3, 5].
Medicine borrows its physicochemical principles from physiology. Study of 
physiological system structure and function, as well as pathophysiological altera-
tions, has its foundations in physical and chemical laws and the molecular and 
cellular makeup of each tissue and organ system. If you know how organs and organ 
systems function in the healthy person, you will find out which components may be 
malfunctioning in a patient.
2. The importance of respiration
Life starts with breathing. As it was written in the Bible God “breathed into 
Adam’s nostrils the breath of life” and then used part of Adam’s ventilatory 
apparatus – a rib – to give life to Eve. Hippocrates suggested that the primary 
purpose of breathing was to cool the heart. In the 18th century the true role of 
breathing began emerged. By the end of the 18th century, chemists and physiolo-
gists studied the chemistry of gases and appreciated that combustion, putrefac-
tion, and respiration all involve chemical reactions that consume O2 and produce 
CO2. Boyle, Henry, Avogadro, and others subsequently stated the theoretical 
foundation for the physiology of O2 and CO2. Considering the recent scientific 
advances, respiration was defined as process, when energy was produced with 
the intake of oxygen and the release of carbon dioxide.
Later work showed that mitochondrial respiration is responsible for the O2 
consumption and CO2 production observed by Spallanzani. This aspect of respira-
tion is often called internal respiration or oxidative phosphorylation. Respiratory 
physiology focuses on external respiration, the dual processes of (1) transporting 
O2 from the atmosphere to the mitochondria and (2) transporting CO2 from the 
mitochondria to the atmosphere. CO2 transport is intimately related to acid-base 
homeostasis.
Traditionally the process of respiration is divided into three phases: (1) cellular 
respiration, (2) transport of respiratory gases and (3) ventilation of the gas exchange 
organs (breathing) [6].
The main goals of respiration are oxygen uptake and elimination of carbon 
dioxide. Secondary goals include acid-base buffering, hormonal regulation, and 
host defense. To achieve the goals of respiration, three main functional components 
of the respiratory system are used: (1) mechanical structures, (2) membrane gas 
exchanger and (3) regulatory system (network of chemical and mechanical sensors  
throughout the circulatory and respiratory systems). All three components are 
tightly integrated, and dysfunction of one can lead to respiratory distress or 
failure [7].
5
Introductory Chapter: Respiratory Physiology
DOI: http://dx.doi.org/10.5772/intechopen.94022
Different kinds of neural receptors are present in the respiratory airways, lungs 
and pulmonary blood vessels:
• Changes in lung volume are perceived by pulmonary stretch receptors and 
muscle spindles.
• Rapidly adapting irritant receptors respond both to changes in lung volume 
and to the presence of chemicals such as histamine, prostaglandins, and 
exogenous noxious agents.
These receptors send the signals to the respiratory centers in the brain via the 
vagus nerve. On the other hand, the respiratory centers affect the breathing pattern 
by increasing the respiratory rate and/or stimulating cough, bronchoconstriction, 
and/or mucus production [8].
Input from these neural receptors likely accounts for the hyperventilation and 
hypocapnia that can occur in patients with pulmonary fibrosis even when hypoxemia 
is reversed by the administration of oxygen. Hyperventilation may occur by this 
mechanism in patients with such problems as asthma, interstitial lung disease, 
pulmonary edema, pneumonia, and pulmonary embolism.
Respiratory centers in the medulla receive stimulatory input from central 
respiratory pacer cells, central and peripheral chemoreceptors, upper airway 
receptors, other areas of the brain, and volitional pathways and integrate these 
signals into a combined output to respiratory muscles to modulate breathing 
frequency, inspiratory time, and expiratory time.
2.1 Developmental considerations
Significant changes occur in respiratory physiology during the transition from 
infancy to childhood, with the development of chest wall structures and maturation 
of the airways and lung parenchyma. Infancy is a time of rapid changes of central 
nervous system, neural respiratory control, as well as developmental plasticity and 
vulnerability. Rib cage geometry becomes more adult-like by about 3 years of age. 
The high chest wall compliance of the newborn decreases with age and becomes 
approximately equal to lung compliance, as in adults, by the second year of life, 
resulting in higher resting lung volume. These changes are important to recognize 
in the clinical setting because infants are more vulnerable to many disease states 
due to higher chest wall compliance, immature control of respiration, and increased 
airway resistance [9].
2.2 Nonrespiratory functions of the respiratory system
The main function of the respiratory system is gas exchange. However, the lung 
performs several nonrespiratory tasks. These functions include: its own defense 
against inspired particulate matter, the storage and filtration of blood for the 
systemic circulation, the handling of vasoactive substances in the blood, and the 
formation and release of substances used in the alveoli or circulation.
There are several ways in which respiratory system prevents from invading patho-
gens compromising the upper airway. Mucociliary clearance provides a strong physical 
barrier, several proteins, antimicrobial peptides, and reactive oxygen species, such as 
nitric oxide, play a significant role in preventing infection. The upper respiratory tract 
also has the ability to sense invading pathogens through Toll-like receptors and taste 
receptors that initiate immune responses [10, 11].
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3. Conclusion
Considering all aspects of respiratory physiology, we can assume that with every 
breath we take, we provide the organism with a power to maintain homeostasis. The 
body carefully controls endless list of vital parameters and is always ready to adapt 
to changing circumstances.
Application of essential principles of physiology and staying up to date to 
constantly changing knowledge in the field is a bridge to treating a patient. 
Remembering physiological and pathophysiological mechanisms and their impact 
on health and disease will help the practitioners throughout their professional 
careers.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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The Respiratory System during 
Intermittent-Sprint Work: 
Respiratory Muscle Work and the 
Critical Distribution of Oxygen
Ramón F. Rodriguez, Robert J. Aughey and François Billaut
Abstract
In healthy individuals at rest and while performing moderate-intensity exercise, 
systemic blood flow is distributed to tissues relative to their metabolic oxygen 
demands. During sustained high-intensity exercise, competition for oxygen 
delivery arises between locomotor and respiratory muscles, and the heightened 
metabolic work of breathing, therefore, contributes to limited skeletal muscle 
oxygenation and contractility. Intriguingly, this does not appear to be the case for 
intermittent-sprint work. This chapter presents new evidence, based on inspira-
tory muscle mechanical loading and hypoxic gas breathing, to support that the 
respiratory system of healthy men is capable of accommodating the oxygen needs 
of both locomotor and respiratory muscles when work is interspersed with short 
recovery periods. Only when moderate hypoxemia is induced, substantial oxygen 
competition arises in favour of the respiratory muscles. These findings extend our 
understanding of the relationship between mechanical and metabolic limits of 
varied exercise modes.
Keywords: blood flow, hyperpnoea, metaboreflex, oxygen uptake, hyperventilation, 
muscle fatigue
1. Introduction
Blood flow to contracting skeletal muscles closely matches their metabolic rate 
[1, 2]. In humans, it has been robustly demonstrated that there is a positive linear 
relationship between the rate of oxygen uptake (VO2) in the quadriceps muscles and 
blood flow through the femoral artery [1], which ensures there is a match between 
oxygen (O2) supply and demand for the exercising muscles. Blood flow is directed 
to areas in need by adjusting vasoconstriction in the relatively inactive regions and 
vasodilatation in the active locomotor muscles [2–4]. During high-intensity and 
maximal exercise, the accompanying increase in cardiac output is almost exclusively 
devoted to the working skeletal muscle [5], whereas blood flow to the splanchnic, 
renal and inactive skeletal muscle tissue beds can fall by ≈70% from resting values 
[6, 7]. It is likely that multiple biological factors contribute to biological redundancy 
in the system [8]. However, there does appear to be a limit to systemic vasodilation, 
a procreative mechanism to maintain arterial blood pressure and ensure adequate 
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O2 supply to vital organs [4, 9–11]. Additionally, when the metabolic demands of 
multiple muscle groups are high, and cardiac output is nearing maximal flow rates, 
competition for available blood flow can arise between muscle groups. One such 
example is the interplay between limb locomotor musculature and the respiratory 
muscles.
The respiratory muscles perform work to overcome the elastic recoil of the lungs 
and chest, resistance from turbulent and viscous airflow through the respiratory 
tract and tissue deformation [12]. As pulmonary ventilation (VE) rises, there is 
an exponential increase in the work being performed by the respiratory muscles 
[12, 13]. This ventilation-induced rise in work of breathing is caused by two factors; 
(1) dynamic hyperinflation to accommodate greater expiratory flow rates [14], and 
(2) progressive increase in the contribution of the expiratory muscles to breath-
ing [15]. As the lungs and chest are progressively stretched to accommodate the 
increasing volume of inhaled air and end-expiratory lung volume is reduced, the 
contribution of elasticity in these tissues to the work of breathing increases [16, 17]. 
Accompanying the changes in work of breathing with VE, there is a certain O2 cost 
of exercise hyperpnoea [13, 18]. By mimicking the ventilation pattern (respiratory 
frequency and tidal volume) obtained during exercise while at rest, it is possible 
to estimate the proportion of whole-body VO2 that is devoted to the respiratory 
muscles. During moderate exercise, the O2 cost of breathing accounts for 3–6% of 
the total whole-body VO2. During high-intensity exercise, the relative contribution 
of exercise hyperpnoea to whole-body VO2 is estimated increases to 10–15% and can 
become a limiting factor of exercise capacity [2, 9, 19–21].
2.  Consequences of sustained respiratory muscle work during 
continuous exercise
The work of breathing associated with high-intensity and maximal exercise is 
responsible for stealing a considerable portion of whole-body VO2, which creates an 
environment where the locomotor and respiratory muscles compete for O2 delivery 
[2, 3]. As such, respiratory muscle work, fatigue and metaboreflex are interrelated 
and suggested to contribute to the development of locomotor muscle fatigue, 
 limiting one’s capacity to sustain high-intensity exercise [9, 22].
An inverse relationship exists between the work of breathing and leg O2 uptake 
during maximal exercise [3]. To reduce the work of breathing, proportional assist 
ventilation (PAV) can be used to generate inspiratory pressure proportional 
to the effort of the patient/subject. Conversely, to elevate inspiratory muscle 
work, a mesh screen can be placed over the inspiratory line, or the aperture of an 
inspiratory port can be reduced. In one such study employing these techniques, 
subjects exercised at a workload sustainable for 2.5–3 min at, or near a work rate 
corresponding to the attainment of VO2max. The work of breathing was attenuated 
by 60% with PAV and increased by 95% with inspiratory loading, compared to 
control during the exercise bout. Elevating the work of breathing had a negligible 
effect on whole-body VO2. Moreover, both leg blood flow and VO2 fell compared to 
control exercise which coincided with an increase in leg vascular resistance. These 
data suggest that cardiac output did not increase to accommodate the additional 
muscular work [2]. It is likely that blood flow was redistributed to the respiratory 
muscles to support the heightened metabolic activity at the expense of the locomo-
tor muscles [3]. When the respiratory muscles were unloaded with PAV, there was a 
slight increase in limb blood flow which corresponded with an increase in leg VO2. 
Thus, by reducing the metabolic demands of the respiratory muscles, O2 delivery 
to the lower limbs can be improved. Taken together, these data indicate that the 
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‘normal’ work of breathing incurred during high-intensity exercise may actually 
be a limiting factor of O2 transport to the locomotor muscle during high-intensity 
exercise [3].
Exercise intensity also plays an important role in the competition between the 
locomotor and respiratory muscles for available O2. While exercising at submaximal 
work rates (50–75% VO2max), there is a small but significant increase in whole-body 
VO2 in response to an elevated work of breathing [23]. Since VO2 responded propor-
tionally to the changes in inspiratory muscle work, is has been concluded that there 
is enough capacity in cardiac output to increase and meet the demands of additional 
muscular work during submaximal exercise [3]. It is only during high-intensity 
exercise when cardiac output approaches maximal flow rates that competition for 
available blood flow begins to develop [3].
Since the high work of breathing during high-intensity exercise (>80% VO2max) 
seems to have a limiting effect on locomotor muscle blood flow, the rate of devel-
opment of peripheral fatigue is likely affected too. To examine exercise-induced 
quadriceps muscle fatigue, supra-maximal femoral nerve stimulation can be used 
to provide an objective measure of muscle force-generating capacity [24]. In one 
such example, peripheral muscle fatigue was assessed after exercise at a work rate 
corresponding to the attainment of 92% of VO2max [25]. On one occasion, subjects 
exercised to volitional exhaustion (13.2 min). On a separate visit, exercise at the 
same work rate and duration was repeated while the respiratory muscles were 
unloaded using PAV (56% reduction of inspiratory muscle work). Following the 
completion of exercise, quadriceps muscle fatigue was 8% greater when subjects 
were not using breathing assistance. To examine how a heightened work of breath-
ing affects peripheral fatigue, exercise was repeated with inspiratory loading (80% 
increase of inspiratory muscle work) to exhaustion (7.9 min). Following the termi-
nation of exercise, the force-generating capacity of the quadriceps was 8% lower 
when performed with inspiratory loading compared to control [25]. These data 
robustly demonstrate that peripheral fatigue can be manipulated by altering the 
work for breathing, which suggests that respiratory muscle work is a limiting factor 
of high-intensity exercise [2, 3].
It is usually unlikely for healthy humans to experience inspiratory loading 
during exercise. However, exposure to (simulated) altitude is a more common 
environmental condition that will increase the work of breathing compared to 
normoxia via stimulation of pulmonary ventilation [26, 27]. To examine the 
relationship between hypoxia-induced elevated work of breathing and peripheral 
fatigue, subjects exercised at a constant work rate (≈273 W) corresponding to 
82% of VO2max in simulated altitude (fraction of inspired oxygen, FIO2 = 0.15) to 
exhaustion [28]. Exercise was then repeated at the same work rate for an identical 
duration in normoxia (≈273 W for 8.6 min). Compared to hypoxia, inspiratory 
muscle work was 36% less when exercising in normoxia and induced a lesser 
reduction in quadriceps force generation (normoxia −16% vs., hypoxia −30%). To 
isolate the effects of the work of breathing on peripheral muscle fatigue, subjects 
repeated both exercise trials (normoxia and hypoxia) using PAV. Inspiratory 
muscle work was nearly identical during exercise between normoxia and hypoxia 
with PAV, and the reduction in hypoxia-induced peripheral fatigue was attenuated 
relative to normoxia (normoxia −15% vs., hypoxia −22%). Combined, these data 
demonstrate that the development of quadriceps fatigue is accelerated in hypoxia 
in part due to heightened inspiratory muscle work. Moreover, this occurs at a work 
rate and exercise duration at which inspiratory muscle work usually does not affect 
quadriceps fatigue [28]. Sustained exercise ≥90% VO2max and the accompanying 
work of breathing may have to reach a given threshold to elicit meaningful changes 
in quadriceps fatigue [25].
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3.  Factors influencing respiratory muscle work during repeated-sprint 
exercise
Repeated-sprints are characterised by brief ‘all-out’ exercise bouts of 4–15 s, 
separated by incomplete recovery periods of 14–30 s [29, 30]. Performance in a 
repeat-sprint context is therefore represented as the ability to reproduce power out-
put after a previous bout of maximal exercise [31]. Over the course of a repeated-
sprint series, there is a progressive decline in total mechanical work performed in 
each successive sprint. The rate of performance decline is also typically accelerated 
in low O2 environments [32]. Initial sprint performance is largely determined by 
muscular strength and power production [33], whereas the ability to resist fatigue 
and maintain performance is underpinned by aerobic capacity and the ability to 
deliver O2 to the locomotor muscles in the recovery periods between sprint recovery 
periods [34, 35]. Below, we outline the work load-induced physiological factors 
known to the work of breathing during intense intermittent exercise.
3.1 Metabolic determinates of repeated-sprint exercise
Resting intramuscular stores of ATP are limited to ≈20–25 mmol·kg−1 of dry 
muscle weight, which during a sprint, can only provide energy for 1–2 s [36, 37]. 
As resting ATP stores become depleted, three major energy systems are respon-
sible for ATP resynthesis. Rapid resynthesis is achieved through phosphocreatine 
(PCr) degradation [36]. Anaerobic glycolysis also has a large involvement in sprint 
metabolism [36]. Though as sprints are repeated, the relative contribution of 
anaerobic glycolysis towards ATP resynthesis declines [36, 37]. Conversely, aerobic 
metabolism has a very small role in isolated sprit performance (≈10% of total ATP 
production), which increases as sprints are repeated [37, 38].
Intramuscular PCr is especially important for the rapid resynthesis of ATP during 
explosive activities via the reversible PCr-creatine kinase pathway [39–41]. In the 
presence of the enzyme creatine kinase, adenosine diphosphate (ADP) is converted 
to ATP through the dephosphorylation of PCr to form creatine (Cr). It is estimated 
that during a single 6-s sprint, 50% of anaerobic ATP production is derived predomi-
nantly through PCr degradation [36]. The remaining anaerobic energy contribution 
during an isolated sprint is supported mainly by glycolysis (44%), and in minority by 
intramuscular ATP stores (6%). When sprints are repeated, the relative contribution 
of PCr to anaerobic ATP resynthesis increases. By the tenth 6-s sprint (each separated 
by 30 s passive rest), PCr degradation is estimated to account for 80% of the total 
anaerobic energy contribution [36]. However, intramuscular PCr stores are limited 
to ≈80 mmol·kg−1 of dry muscle weight, and after only a single 6-s sprint, stores are 
reduced ≈50% from baseline [36, 42]. When multiple sprints are performed, PCr 
depletion can be up to 75% after 5 repetitions [42], and 84% after 10 [36]. Since PCr 
degradation has such a large contribution to ATP resynthesis, the recovery of intra-
muscular stores PCr is critically important to the restoration of power output [43].
The capacity to recover PCr is limited in a multiple sprint series, largely con-
strained by the short recovery periods between sprints. The rate of PCr resynthesis 
follows an initial fast phase, followed by a second longer slow component [44]. 
After a single 6-s sprint, approximately 70% of PCr replenishment is achieved 
in the first 30 s of passive rest [42]. But as sprints are repeated and muscle stores 
are further depleted, PCr can only recover to 50% of resting stores after just five 
repetitions. When rest is extended post a repeat-sprint series, only 80% of PCr is 
recovered after 3 min [42], and 85% after 6 min of passive rest [45]. Though PCr 
degradation is an anaerobic process, PCr resynthesis is an aerobic process and is 
sensitive to O2 availability [43, 44, 46, 47]. When breathing a hypoxic gas mixture 
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(FIO2 = 0.10), the rate of PCr resynthesis has been demonstrated to be attenuated 
by 23% [46]. While breathing a hyperoxic gas (FIO2 = 1.00) enhances recovery by 
20% compared with normoxia, which suggests that under normal exercise condi-
tions PCr resynthesis is limited by O2 availability [46]. Therefore, if the work of 
breathing is high enough to limit locomotor muscle O2 delivery, PCr resynthesis in 
repeated-sprint exercise may be impaired.
The energy debt created by the rapid decrease in muscle PCr during a single 
sprint is met by a sizable contribution of anaerobic glycolysis to ATP resynthesis. 
Approximately 44% of ATP resynthesis is derived from anaerobic glycolysis during 
a single 6-s sprint [36]. However, the relative contribution of anaerobic metabolism 
declines as sprints are repeated [48]. By the tenth sprint, Gaitanos, Williams [36] 
estimated that glycolysis was only responsible for 16% of total anaerobic ATP 
production. Moreover, in four of the seven subjects, it was estimated to be zero 
(range 0–23.1 mmol ATP·kg−1 of dry muscle weight). Many mechanisms play a role 
in the relative decrease in anaerobic glycolysis during multiple-sprint work. The 
most likely being the progressive depletion of muscle glycogen that is associated 
with high-intensity activity [49].
The aerobic contribution to an isolated sprint is minimal since the maximal rate 
of ATP resynthesis is far below the requirements of maximal sprint work [39]. In an 
isolated sprint, aerobic metabolism is responsible for ≈10% of total energy produc-
tion [37, 48]. But as sprints are repeated, the relative increase in aerobic metabolism 
to total ATP turnover rate rises to compensate for reduced energy supply from 
anaerobic pathways [38]. Following five 6-s sprints, it is estimated the aerobic 
energy contribution rises to ≈40% of total ATP production [48]. The remaining 
60% is derived from anaerobic pathways, predominantly PCr degradation [36, 42]. 
Pulmonary VO2 can fluctuate between 70 and 100% of VO2max from sprint to recov-
ery periods in the latter stages of a repeat-sprint series [50]. When no external work 
is being performed (i.e., passive rest) during the recovery period between sprints, 
the elevated VO2 above baseline is representative of lactate metabolism, removal of 
inorganic phosphate, and most importantly PCr resynthesis [40, 51].
Aerobic metabolism may have a limited role in ATP formation during multiple 
sprint work [38, 48], but is fundamental to PCr resynthesis between sprints. 
Compartment specific creatine kinase isozymes are located in the cytosol and mito-
chondrial intermembrane space, and are associated with either the ATP-consuming 
or -delivering process, respectively [40, 41]. In the PCr shuttle system, mitochon-
drial creatine kinase mediates the reaction between creatine and ATP formed by 
oxidative metabolism, to generate PCr and ADP [40]. Therefore, the rate at which 
the mitochondria can generate ATP through oxidative phosphorylation, will dictate 
PCr resynthesis. A positive correlation between aerobic fitness and maintaining 
repeat-sprint performance exists [31, 34, 52, 53]. It is likely that improvements 
in mitochondria function and content, that are associated with exercise training 
[54], underpin the correlation between aerobic fitness and repeated-sprint ability. 
Additionally, muscle O2 availability between sprint efforts likely affects mitochon-
drial oxidative phosphorylation, which would explain the connection between PCr 
resynthesis and O2 availability [43, 46]. Therefore, the ability to deliver O2 to the 
locomotor muscles during rest periods between sprints is critical to maintaining 
maximal sprint performance [35, 47].
3.2 Muscle oxygenation and repeated-sprint exercise
Muscle O2 availability during repeated-sprint exercise is critical for support-
ing PCr resynthesis, which underpins the capacity to maintain power out over a 
sprint series [36, 46]. Changes in local O2 balance (delivery vs. consumption) can 
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3.2 Muscle oxygenation and repeated-sprint exercise
Muscle O2 availability during repeated-sprint exercise is critical for support-
ing PCr resynthesis, which underpins the capacity to maintain power out over a 
sprint series [36, 46]. Changes in local O2 balance (delivery vs. consumption) can 
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be measured in real-time with near-infrared spectroscopy (NIRS) [55]. The NIRS 
technology relies on the relative transparency of biological tissue to near-infrared 
light (650–950 nm), and light absorption of deoxyhaemoglobin and oxyhaemoglo-
bin [56]. The concentration of deoxyhaemoglobin ([HHb]) and oxyhaemoglobin 
([O2Hb]) rises and falls, respectively, proportional to an increase in metabolic activ-
ity in the underlying tissue and display similar kinetics to pulmonary VO2 [50, 57]. 
The analysis is typically focused on [HHb] since it is less sensitive to fluctuations in 
total haemoglobin, is assumed to reflect venous [HHb] and thus muscular oxygen 
extraction, and because [O2Hb] is influenced by rapid blood volume and perfusion 
variations due to the skeletal muscle pump.
Because PCr resynthesis is achieved through oxidative processes [46, 58], the 
availability of muscle O2 during rest periods is critically important for metabolic 
recovery. In maximal voluntary isometric handgrip exercise, reoxygenation rate 
measured as the rate change of [O2Hb] during recovery was strongly correlated 
with the recovery of muscle PCr (r2 = 0.939) [47]. Therefore, factors affecting 
muscle reoxygenation between sprint efforts will likely affect PCr resynthesis and 
repeated-sprint performance.
Vastus lateralis reoxygenation capacity can be attenuated by performing low-
intensity activity (jogging/cycling) between sprint efforts [50, 59]. By reducing O2 
availability, the restoration of peak cycling power and peak running speed follow-
ing periods of ‘active’ recovery is 3–7% lower compared to passive rest. The time to 
exhaustion is also lowered by performing ‘active’ recovery when performing 15-s 
sprints, repeated every 15 s (745 ± 171 s vs. 445 ± 79 s; −60%) [60]. Performing 
active recovery between sprints, muscle tissue reoxygenation is impaired through 
the constant O2 uptake supporting the metabolic requirements of the active 
recovery. Therefore, PCr resynthesis is likely blunted because ATP from oxidative 
phosphorylation is devoted directly to maintain muscle contractions, rather than 
towards PCr resynthesis [41, 59].
The influence of limited reoxygenation on repeated-sprint ability has also been 
highlighted by manipulating the FIO2. When performing ten 10-s sprints with 30 s 
of passive rest and inspiring a hypoxic gas mixture (FIO2 = 0.13), reoxygenation was 
attenuated by 11% [35]. There was a ≈ 8% reduction in total mechanical work in 
hypoxia compared to normoxia, and the reduction in work was strongly correlated 
with the attenuated muscle reoxygenation (r = 0.78; 90% confidence interval: 0.49, 
0.91). Since PCr resynthesis has similar recovery kinetics to reoxygenation [47], it is 
likely that muscle PCr recovery was hindered by limited O2 availability. Therefore, 
enhancing the capacity to reoxygenation the muscle between sprints is likely to have 
positive benefits for repeated-sprint ability.
There exists a positive relationship between aerobic fitness and repeated-sprint 
ability, which may in part be explained by superior reoxygenation capacity [31, 34, 
52, 53]. After 8 weeks of endurance training, although the initial sprint performance 
is typically unaffected [61] (presumably because improvements in aerobic function 
do not support the anaerobic nature of an isolated sprint), muscle oxygenation was 
reported to be 152% higher prior to the commencement of the second sprint follow-
ing training. Consequently, the decrement in performance within the subsequent 
sprint was attenuated by 26% [61]. It is likely that by improving O2 delivery to the 
locomotor muscle, O2 availability for oxidative phosphorylation was enhanced, and 
in turn, the phosphocreatine shuttle system [39, 40].
3.3. Heightened inspiratory muscle work
As described in Section 2, respiratory muscle work has been implicated as a 
limiting factor of limb O2 perfusion during continuous exercise [9]. However, 
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competition between locomotor and respiratory muscle for available cardiac 
output does not appear to be a significant limiting factor of performance dur-
ing repeated-sprint exercise. In our recent work, we examined the influence of 
inspiratory muscle loading on oxygenation trends in repeated-sprint exercise [62]. 
Participants were asked to perform ten 10-s cycle ergometer sprints, each separated 
by 30 s of passive rest. Inspiratory loading was achieved by placing a plastic disk 
with a 10-mm opening over the inspiratory side of a two-way non-rebreathing 
valve (Figure 1). Inspiratory muscle force development (calculated as the integral 
of inspiratory mouth pressure, multiplied by respiratory frequency) was similar to 
others who have shown vastus grater lateralis muscle deoxygenation with inspira-
tory loading during exercise [63]. In response, whole-body VO2 measured at the 
mouth was elevated by 4–5% during both the sprint and recovery phases (Figure 2) 
[62]. This occurred even though total sprint work was similar between the condi-
tions. The elevation in VO2 was likely driven by a heightened oxygen O2 uptake by 
the respiratory muscle to accommodate for the additional inspiratory muscle work 
[23, 63]. Importantly, Tissue Saturation Index (TSI = [O2Hb] ÷ ([O2Hb] + [HHb]), 
expressed in %) measured at the sixth intercostal space, was comparable between 
the conditions, which suggests that O2 supply to the respiratory muscles remained 
proportional to the metabolic activity. The change in inspiratory muscle work did 
not translate into compromised vastus lateralis oxygenation.
The intermittent nature of repeated sprints is likely a key mediating  factor 
for which O2 delivery can be maintained to both locomotor and respiratory 
Figure 1. 
Representation of how inspiratory loading was achieved [62]. A plastic disk with a 10-mm opening was placed 
over the inspiratory side of a two-way non-rebreathing valve (Hans Rudolph Inc., Kansas, United States of 
America) attached to the distal end of a bidirectional turbine and held in place by the internal ridge of a 
rubber tubing adaptor. A pressure transducer was attached to the saliva port of the non-rebreathing valve via 
Tygon tubing to assess inspiratory mouth pressure.
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muscles. Others have demonstrated that the addition of an inspiratory load while 
exercising >95% VO2max, results in a decrease in limb perfusion and O2 delivery, 
mediated by sympathetically-activated vasoconstriction in the locomotor muscles 
[2, 3]. Whereas during moderate intensities (50–75% VO2max), there is no change 
in vascular resistance or blood flow [23]. Even though repeated-sprint exercise 
can elicit >90% of VO2 peak, it is not sustained throughout the entire protocol 
and can fluctuate between 70 and 90% of VO2max between sprint and recover 
phases [50, 62]. The fluctuation in metabolic demands between the phases likely 
minimises the potential for a competition for available cardiac output. Moreover, 
since VO2 was able to increase, these data highlight the capacity of the cardiore-
spiratory system to rapidly adjust and meet the additional metabolic demands 
imposed by inspiratory loading even during severe exercise [64]. In instances 
where blood flow is impacted by additional respiratory muscle work, there is no 
compensatory increase in VO2 [2, 3]. Therefore, having the capacity to increase 
VO2 may be a crucial factor in maintaining O2 supply to all active muscles dur-
ing high-intensity exercise and, thereby, sustain prolonged periods of physical 
activity.
3.4 Acute environmental hypoxia
To further explore the role of O2 availability in balancing the metabolic demands 
of the locomotor and respiratory muscles, we asked participants to exercise in 
an environment where the O2 concentration had been reduced to 14.55% [65]. 
Participants completed the same protocol as previously described (ten 10-s sprints, 
30 s of passive rest) while vastus lateralis and intercostal muscle oxygenation was 
assessed with NIRS. Surprisingly, there was no clear difference in repeated-sprint 
ability in hypoxia compared to normoxia. However, there was a clear reduction in 
vastus lateralis muscle oxygenation similar to previous research (Figure 3) [35, 66]. 
Ventilation patterns (respiratory frequency and inspiratory volume) and inspira-
tory pressure generation were similar between conditions. Therefore, the O2 cost of 
Figure 2. 
Sprint and recovery pulmonary oxygen uptake (VO2) expressed as a percentage of VO2peak for control 
(CTRL), inspiratory muscle loading (INSP), and worked matched (MATCH) exercise. The symbols represent 
comparisons between INSP and CTRL (*), INSP and MATCH (#). The number of symbols; one, two, and 
three denote likely, very likely and almost certainly respectively, that the chance of the true effect exceeds a small 
(−0.2 to 0.2) effect size. Values are presented as mean ± SD. Reproduced from Rodriguez et al. [62] under a 
Creative Commons Attribution 4.0 licence.
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exercise hyperpnoea was likely similar between conditions [67]. However, there was 
no clear difference in respiratory muscle oxygenation ([O2Hb] and [HHb]) during 
exercise in hypoxia when compared to normoxia (Figure 4) [65]. Based on this new 
evidence, it appears that O2 delivery is preferentially distributed to the respiratory 
muscles to maintain the metabolic function of the respiratory muscles.
Locomotor muscle O2 availability during rest phases between sprints is a strong 
determining factor of metabolic recovery [36, 37, 44], and thus performance over 
multiple sprints [35]. Based on our early research, it seems that locomotor muscle 
O2 availability is compromised in hypoxia in favour of the respiratory muscles. 
Others have reported exaggerated deoxygenation of the respiratory muscles in 
hypoxia during voluntary isocapnic hyperpnoea [68]. However, their hypoxia gas 
mixture (10% O2) resulted in a lower arterial O2 saturation of 82% (estimated via 
pulse oximetry) compared to the average 87% in subjects of the study discussed 
here [65]. A hypoxic threshold may exist where respiratory muscle O2 delivery 
can be maintained close to the rate of that during exercise in normoxia. If arterial 
hypoxemia was greater, further desaturation of the respiratory muscles may have 
been detected. Amann et al. [28] have reported a link between inspiratory muscle 
Figure 3. 
Vastus lateralis muscle oxygenation trends during repeated-sprint exercise in normoxia and hypoxia expressed 
as a percentage of arterial occlusion. (a) Change of vastus lateralis oxyhaemoglobin (O2HbVL); and (b) 
vastus lateralis deoxyhaemoglobin (HHbVL). The number of symbols (*); one, two and three denote likely, 
very likely and most likely respectively, that the chance of the true effect exceeds a small (−0.2 to 0.2) effect 
size. Results are presented as mean ± SD. Reprinted from Rodriguez et al. [65], with permission from Elsevier.
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exercise hyperpnoea was likely similar between conditions [67]. However, there was 
no clear difference in respiratory muscle oxygenation ([O2Hb] and [HHb]) during 
exercise in hypoxia when compared to normoxia (Figure 4) [65]. Based on this new 
evidence, it appears that O2 delivery is preferentially distributed to the respiratory 
muscles to maintain the metabolic function of the respiratory muscles.
Locomotor muscle O2 availability during rest phases between sprints is a strong 
determining factor of metabolic recovery [36, 37, 44], and thus performance over 
multiple sprints [35]. Based on our early research, it seems that locomotor muscle 
O2 availability is compromised in hypoxia in favour of the respiratory muscles. 
Others have reported exaggerated deoxygenation of the respiratory muscles in 
hypoxia during voluntary isocapnic hyperpnoea [68]. However, their hypoxia gas 
mixture (10% O2) resulted in a lower arterial O2 saturation of 82% (estimated via 
pulse oximetry) compared to the average 87% in subjects of the study discussed 
here [65]. A hypoxic threshold may exist where respiratory muscle O2 delivery 
can be maintained close to the rate of that during exercise in normoxia. If arterial 
hypoxemia was greater, further desaturation of the respiratory muscles may have 
been detected. Amann et al. [28] have reported a link between inspiratory muscle 
Figure 3. 
Vastus lateralis muscle oxygenation trends during repeated-sprint exercise in normoxia and hypoxia expressed 
as a percentage of arterial occlusion. (a) Change of vastus lateralis oxyhaemoglobin (O2HbVL); and (b) 
vastus lateralis deoxyhaemoglobin (HHbVL). The number of symbols (*); one, two and three denote likely, 
very likely and most likely respectively, that the chance of the true effect exceeds a small (−0.2 to 0.2) effect 
size. Results are presented as mean ± SD. Reprinted from Rodriguez et al. [65], with permission from Elsevier.
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work in hypoxia and the development of quadriceps fatigue during high-intensity 
exercise. By reducing the work of breathing with PAV, the rate of fatigue develop-
ments can be attenuated [28]. Therefore, alleviating the O2 cost of exercise hyper-
pnoea appears to be a pathway for enhancing limb O2 delivery and exercise capacity 
in humans.
Figure 4. 
Respiratory muscle oxygenation trends during repeated-sprint exercise in normoxia and hypoxia expressed 
as an absolute change from baseline (horizontal line). (a) Concentration change from baseline of respiratory 
muscle oxyhaemoglobin ([O2HbRM]); (b) respiratory muscle deoxyhaemoglobin ([HHbRM]); and (c) 
respiratory muscle total haemoglobin ([tHbRM]). There was no clear effect of hypoxia on respiratory muscle 
oxygenation compared to normoxia. Results are represented as mean ± SD. Reprinted from Rodriguez et al. 
[65], with permission from Elsevier.
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3.5 Respiratory muscle training
Aside from the structural characteristics of the pulmonary system, the rela-
tive strength of the respiratory muscles is likely to have a key role in the O2 cost 
of exercise hyperpnoea. After 6-weeks of inspiratory muscle strength training, 
is has been demonstrated that ventilation O2 efficiency can be enhanced [19]. 
Specific training targeting the inspiratory muscles (inspiratory muscle training, 
IMT) typically consists of inspiring against a closed valve set to open at ≈50% of 
an individual’s maximal inspiratory mouth pressure, repeated 30 times twice per 
day. Strengthening the inspiratory muscles has translated to reduced O2 cost of 
voluntary hyperpnoea, attenuated exercise-induced respiratory muscle fatigue, 
attenuated vastus lateralis and respiratory muscle deoxygenation, and improved 
exercise capacity [19, 67–70]. However, respiratory muscle fatigue has not been 
clearly demonstrated for multiple-sprint work, and therefore ergogenic benefits 
of respiratory muscle training for improving repeated-sprint alibility may be 
limited [71]. Nevertheless, evidence that IMT provides some benefit towards 
maintaining repeated-sprint performance exists, though the mechanisms are 
unclear [72, 73].
After a 6-week period of IMT, repeated-sprint ability was assessed in a group 
of recreational sprint sports players (soccer, rugby, field hockey and basketball) 
[72]. Performance was assessed during fifteen 20-m sprints, which participants 
were allowed a maximum of 30 s rest. Following the intervention, there were no 
clear changes in sprint times. However, self-selected recovery time was lessened by 
6.9% (range: −0.9 to 14.5%). Strengthening the inspiratory muscles presumably 
reduced the O2 cost of exercise hyperpnoea and blunted the respiratory muscle 
metaboreflex, which would, in turn, reduce O2 competition between locomotor and 
respiratory muscles [9, 19, 74]. Through minimising O2 competition, it is likely that 
the quality of metabolic recovery was enhanced with IMT, so that subjects could 
maintain performance with less rest between sprints [72]. But since there were no 
measurements of muscle oxygenation, it is difficult to separate potential changes 
in O2 delivery from reduced feelings of dyspnoea that is associated with respiratory 
muscle training [69, 72].
The effectiveness of IMT on repeat-sprint ability and run time to exhaustion at 
100% of the speed obtained during a maximal incremental exercise test has also 
been assessed in a group of professional female soccer players [73]. Repeated-sprint 
ability was assessed with six 40-m sprints (20 m + 180° turn +20 m) with 20 s of 
passive rest between sprints. Vastus lateralis and intercostal muscle oxygenation 
was only examined during the time-to-exhaustion trials. There was no significant 
difference between the groups in repeated-sprint ability (P > 0.05). However the 
effect size for performance decrement was slightly larger in the IMT group post 
intervention (Cohen’s d = 0.84 vs. 0.16). Similar, both placebo and experimental 
groups improved time to exhaustion with no significant difference between groups, 
but the effect size in the IMT group was larger (Cohen’s d = 0.74 vs. 0.46). Specific 
training of the respiratory muscles, therefore, may only provide negligible/small 
performance benefits beyond professional soccer periodised training. Performance 
benefits were partly attributed to a blunted increase in respiratory muscle [HHb], 
with a concurrent increase in vastus lateralis [O2Hb] [73]. In terms of the athlete’s 
ability to preserve repeat-sprint performance, the IMT group also showed the 
greatest improvement in the capacity to maintain sprint time over multiple sprints. 
The blunted respiratory muscle metaboreflex in the exhaustion test may have also 
occurred during the repeated-sprint test. However, without muscle oxygenation 
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The few studies demonstrating enhanced repeated-sprint performance follow-
ing IMT [72, 73] support the notion that respiratory muscle work plays a negative 
effect on high-intensity intermittent exercise. Training the respiratory muscles can 
reduce the O2 cost of exercise hyperpnoea [19], and attenuate blood flow competi-
tion between the locomotor and respiratory muscles [70, 74]. However, there 
remains a very limited understanding of the role exercise hyperpnoea plays during 
repeated-sprint exercise. Research still needs to answer if the enhanced repeated-
sprint ability following respiratory muscle training is derived from improved 
skeletal muscle oxygenation kinetics.
3.6 Evidence for hyperventilation
Hyperventilation is demarcated when alveolar ventilation disproportionally 
rises relative to CO2 production causing a decrease in the pressure of alveolar 
CO2, and an increase in the pressure of alveolar O2 [75]. Hyperventilation read-
ily occurs during high-intensity exercise and can constrain a fall in arterial O2 
and pH [75, 76]. Though this was not directly examined in our research [62, 65], 
some evidence of hyperventilation occurring during repeated-sprint exercise was 
present. As depicted by the data of a representative subject (Figure 5), the partial 
pressure of end-tidal oxygen (PETO2) and carbon dioxide (PETCO2) rose and fell 
respectively from baseline over the course of the repeated-sprint protocol [62]. 
The wave-like pattern in PETO2 and PETCO2 appears to be linked to the phase of the 
protocol (sprint vs. rest) and occurs at exercise onset. This pattern is suggestive 
of a locomotor respiratory coupling, in which breathing frequency matches the 
cadence of locomotor exercise [77].
Further new evidence of hyperventilation comes from our recent hypoxia 
research [65]. Arterial hypoxemia is a potent stimulus of ventilation [26–28]. 
However, as we reported, there was no clear difference in either inspiratory 
volume, respiratory frequency or inspiratory mouth pressure during the repeated-
sprint protocol. One may argue that participants were already operating at their 
Figure 5. 
Partial pressure of end-tidal oxygen (PETO2) and carbon dioxide (PETCO2) recorded on a breath-by-breath 
basis during repeated-sprint exercise. Data are from a single subject collected as part of the study by Rodriguez 
et al. [62] during the control exercise condition. The exercise protocol consisted of ten 10-s sprints, separated by 
30 s of passive rest so that a sprint commenced every 40 s. The grey shaded area represents the 2-min baseline 
period observed prior to the commencement of warm-up.
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upper limits of ventilation, and thus arterial hypoxemia could not have had an 
additive effect. Although appealing, such hypothesis requires additional work to 
determine the influencing factors of exercise hyperpnoea over a variety of sprint 
durations.
4. Conclusion
The findings of our research do not support heightened inspiratory muscle work 
as being a limiting factor in vastus lateralis muscle oxygenation in normoxia. The 
intermittent nature of repeated-sprint activity is likely a key mediating factor for 
which O2 delivery can be maintained to both the locomotor and respiratory muscles. 
Moreover, reducing the relative intensity of exercise hyperpnoea through inspira-
tory muscle training shows limited benefits for enhancing repeated sprint ability. 
Inspiratory muscle work appears to play a more influential role under conditions of 
arterial hypoxemia. Our research showed that locomotor muscle oxygenation can 
be compromised through preferential O2 delivery to the respiratory muscles. It is yet 
to be seen if inspiratory muscle training could be of benefit to exercise under these 
conditions.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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Moreover, reducing the relative intensity of exercise hyperpnoea through inspira-
tory muscle training shows limited benefits for enhancing repeated sprint ability. 
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Abstract
Patients with chronic respiratory diseases (CRDs) have a disorder in muscle
structure and function, but their function increases with physical progress and
decreases the risk of general, and muscular weakness are more likely to develop
sarcopenia. We randomly selected patients (N = 38) with mean age of 72  1.0
years old men and women elderly with chronic respiratory diseases such as asthma,
COPD, bronchiectasis and obesity with dyspnea score ≥ 2 in MRC index. All
patients after receiving research information and signing informed consent have
gone through performing clinical assessments. They performed femur bone mineral
density (FBMD) and ultrasound on the rectus femoris muscle mid-tight cross-
sectional area (RFMTCSA) in the quadriceps muscle. The significant changes in
BMI were seen in all patients, pre-rehabilitation, BMI = 30  1.06 kg/m2 and post-
rehabilitation, BMI = 29 1.00 kg/m2. In Pearson’s correlation of r = 0.607 between
T-score and Z-score in FBMD and RFMTCSA in pre-rehabilitation, there is a little
bit significant correlation between the variables than in the Pearson’s correlation of
r = 0.910 in post-rehabilitation, P < 0.00. Comparing femur bone and rectus
femoris muscle parameters as indicators for diagnosis of sarcopenia in chronic
respiratory patients, we observed that in rectus femoris muscle, ultrasound is the
most effective foot muscle detector.
Keywords: sarcopenia, femoral bone mineral density, rectus femoris muscle
phenotype, quadriceps muscles, chronic respiratory disease, quality of life
1. Introduction
Chronic respiratory disease (CRDs) is widespread worldwide. It was reported to
be the sixth leading cause of death in the world in 1990 and is now the fourth
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1. Introduction
Chronic respiratory disease (CRDs) is widespread worldwide. It was reported to
be the sixth leading cause of death in the world in 1990 and is now the fourth
leading cause of death and is projected to be the third leading cause of death in the
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world by 2020 [1]. Chronic obstruction of airflow is an important feature of these
patients. CRDs have impaired airway function and lung structures. Some of the
most common chronic obstructive pulmonary diseases, COPD, asthma, occupa-
tional lung disease, pulmonary hypertension and respiratory problems associated
with the patient are due to adverse physical conditions such as for overweight and
obesity. Patients with chronic respiratory illness can suffer from other symptoms
such as frailty, depression, heart attack, fatigue, decreased exercise capacity, and
kidney pain. Exercise is in many cases a strategic way to improve the symptoms of
these diseases. It is now widely reported that proper exercise can be an effective
prevention and treatment strategy for respiratory patients, and this is very impor-
tant in the management of elderly people with chronic respiratory diseases. Recent
studies of extra-pulmonary issues in chronic respiratory patients have shown that
quadriceps muscle is the most important muscle for these patients due to involve-
ment in movement and activities [2, 3]. But accurate and reliable equipment must
be used to evaluate the quadriceps. New scientific studies have used ultrasound
technology as an important and valid device for an accurate evaluation of
quadriceps function and structure.
According to the latest scientific reports [4, 5], the rate of sarcopenia in COPD
patients is about 25%. Severe sarcopenia was 2.5% and only 0.8% obesity associated
with sarcopenia. The incidence of sarcopenia in COPD patients is 15%. It is well
known that respiratory disorders are a very common disease. It is also quite evident
that respiratory distress is a very common disease that affects up to 10% of adults
over 40 years of age and causes high levels of illness and mortality. It is associated
with additional respiratory disorders, such as cardiovascular disease, osteoporosis,
depression, and anemia. Besides, other non-pulmonary complications, such as car-
diovascular disease, bone loss, musculoskeletal disorders, and muscle weakness, can
also adversely affect their health outcomes. Increasing different comorbidities can
damage lung function, decrease quality of life, and increase mortality. In all of these
problems, muscle weakness and osteoporosis is a major problem that needs more
therapeutic intervention. In the general population, osteoporosis risk factors include
female gender, age, low body weight, glucocorticoid intake in chronic patients, and
endocrine problems such as hyperthyroidism and primary hyperparathyroidism.
Recently, reduced skeletal muscle as sarcopenia parameter has been identified as a
risk factor [6]. The major risk factors for osteoporosis in respiratory patients are not
yet clearly understood, but factors such as aging, female gender, low body weight,
and body mass index (BMI) have been associated with reduced BMD in patients
with COPD [6]. But compared to skeletal muscle index, body weight and BMI do
not provide a more accurate reflection of body composition. In one study of aging
and body composition, the prevalence of sarcopenia in the overweight group
(BMI = 25–29) was 8.9% and in the obese group (BMI > 30) 7.1%. Overweight
and obesity are often symptoms of sarcopenia and gradually increase with the
prevalence of chronic respiratory disease. Low body mass index is associated with
osteoporosis risk factors in patients with COPD including low body weight and low
BMD [7]. Sarcopenia is a major complication of chronic obstructive pulmonary
disease, which is often seen even without low BMI. However, few studies have been
published on the relationship between sarcopenia and BMD.
1.1 Skeletal muscle dysfunction in CRDs
Musculoskeletal disorders are an important clinical examination that is recog-
nized in chronic respiratory patients. For example, in people with COPD, common
changes in the musculoskeletal system, including quadriceps weakness, atrophy,
and fiber-type shift, each provide independent predictive information of the lung.
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The mechanism that disrupts musculoskeletal function can have negative conse-
quences through the progression of the so-called “healthy age” to sarcopenia and
weakness. Sarcopenia has been described as a decrease in skeletal muscle and a
decrease in physical function dependence, which requires knowledge of current
conditions of the musculoskeletal system to reduce muscle mass and muscle weak-
ness in chronic respiratory patients. Skeletal muscle function is often considered in
common diagnostic criteria, due to muscle weakness and a history of weight loss,
which is often a product of muscle wasting. Both syndromes indicate skeletal
muscle dysfunction, which affects more of these syndromes, the broader effects of
the disease, both inside and outside the lungs, affecting morbidity and mortality in
these patients [8]. Therefore, the presence of sarcopenia may be considered and
provide additional prognostic information provided by skeletal muscle function
markers. Previous studies have reported that a decrease in skeletal muscle mass is
associated with a decrease lung function in patients with COPD. More recently, in
studies of nursing home residents, Carlson et al. [6] showed that peripheral muscle
strength, including hand-grip strength, was associated with maximal stimulating
muscle strength. However, there is a paucity of information on how skeletal
muscle mass changes are associated with pulmonary function in adults without lung
disease.
1.2 Recognizing sarcopenia in CRDs
Some scientific reports suggest that one of the systemic effects of COPD is
sarcopenia. The term is described as an age-related decline in muscle volume and
function. This situation is associated with negative health consequences such as
falling, disability, hospitalization, poor quality of life and mortality. The cause of
sarcopenia is in addition to the consequences of the disease, nutrition, and activities
caused by physiological changes. Sarcopenia can be classified as a physical impair-
ment associated with adverse health consequences. These findings suggest that
sarcopenia is associated with decreased lung function in COPD patients. These
patients also have a relative or absolute increase in fat mass, which can lead to
systemic inflammation, and insulin resistance [9, 14]. In a recent study, body mass
index (BMI) was not significantly associated with lung function, the severity of
dyspnea, quality of life, and decreased skeletal muscle mass.
Skeletal muscle dysfunction is a well-known clinical manifestation in COPD
patients. Key features include quadriceps weakness, atrophy, and type II fiber
alteration, all of which are associated with a poor prognosis independent of lung
function. Sarcopenia describes age-related skeletal muscle loss, leading to an
increased risk of physical disability, poor health, and mortality. Sarcopenia is
increasingly recognized as a clinical syndrome with its contributing factors, includ-
ing physical inactivity, malnutrition, and chronic illness. Since COPD is in some
ways an accelerated disease in the aging process, it is proposed the hypothesis that
sarcopenia is related to COPD patients [10]. In patients with COPD, most studies
addressing skeletal muscle dysfunction have focused on one aspect of sarcopenia,
mainly in the lower limbs. This contradicts international consensus statements on
sarcopenia, which emphasizes the loss of both muscle mass and function in diag-
nostic criteria, and emphasizes the importance of general muscle function. In par-
ticular, evaluation of one aspect of sarcopenia is not sufficient, as the relationship
between muscle mass and strength is nonlinear, and muscle atrophy does not
always lead to dysfunction and there are no functional status weaknesses. The
European Working Group on Sarcopenia in the Elderly (EWGSOP) has developed
practical clinical diagnostic criteria for sarcopenia approved by international orga-
nizations and used to assess the prevalence and impact of this syndrome on disease
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settings and states. Although commonly used in COPD, it is necessary to under-
stand the magnitude and nature of the problem in the disease associated with
atrophy and muscle weakness [11]. Sarcopenia is associated with many common
disease management strategies, including exercise training and nutritional aspects.
Given the emergence of drugs directed to sarcopenia in other disease conditions,
such data may be useful for drug production [12]. In this study, we evaluated the
prevalence and risk factors of sarcopenia in respiratory patients and the effect of
sarcopenia on functional exercise capacity and health status. We also seek to exam-
ine the relationship between sarcopenia and quadriceps strength and to examine
whether exercise training as part of pulmonary rehabilitation can reverse
sarcopenia.
Patients with respiratory disorders have musculoskeletal disorders, but their
function increases with the progression of physical activity and reduces the risk of
general and muscular weakness. Respiratory patients with general and muscular
weakness have higher mortality rates than non-weak patients and are more likely to
have sarcopenia and an increased incidence of the disease. In one study at a British
hospital (2015) [13], the prevalence of sarcopenia was reported to be 14.5% of
COPD patients in British country compared to other European countries. In chronic
respiratory patients, both risk factors (smoking, aging) and their causal mecha-
nisms (endocrine dysfunction and inflammatory cytokines) are common and be
high prevalence. These causes have increased with age and the global prevalence of
recurrent respiratory diseases. Muscle structure and function must be considered
for the diagnosis of sarcopenia. Clinically, the current definition of sarcopenia may
show several defects, especially for quantitative measurement of muscle volume.
Firstly, muscle mass thresholds are defined differently, and this causes patients to
be classified correctly or incorrectly for sarcopenia. The prevalence of sarcopenia in
the elderly also depends on the accepted definition for evaluation. However, the
role of skeletal muscle ultrasound for screening and diagnosis of sarcopenia in the
elderly remains and is important. None of the current definitions of sarcopenia
include it in the diagnostic algorithms currently in the category of specialists.
However, some experts [14–16] believe that using ultrasound in this field is also
useful and this technique is recognizable based on pioneering studies of muscle
mass in healthy individuals and patients with an aging approach. Therefore, most
studies support the use of potentially validated muscle ultrasound to identify
sarcopenia in the elderly. However, since it has been performed in small samples
and a variety of clinical conditions (from healthy subjects to patients with chronic
diseases), no significant recommendations have been made regarding the use of
large-scale muscle ultrasound. In smaller cases, so in the same patients, some mus-
cles may be affected by sarcopenia and other muscles not affected. Innovative
muscle ultrasound studies have been conducted by Abe et al. [19] and his colleagues
have contributed to the development of knowledge of this phenomenon and have
developed specific concepts. They also developed and validated the equations, and
calculated the total body mass index from ultrasound muscle thickness measure-
ments in Japanese and Caucasian subjects, and achieved significant results.
However, the relationship between full-body sarcopenia and specific sarcopenia is
not fully understood and needs further research to identify the indicators. In this
capture, in a small group of healthy adults, the researchers showed that the ratio of
anterior or posterior muscle to ultrasound was not consistent with abdominal lum-
bar mass measured by DEXA. However, according to the researchers’ findings, it
can be concluded that using ultrasound and DEXA to predict sarcopenia indices in
chronic respiratory patients is valid and reliable, but which parameter has the most
impact? It is not clear yet and we need to investigate more in the future. However,
the role of skeletal muscle ultrasound for screening and diagnosis of sarcopenia in
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the elderly is quite clear. But none of the current indicators of sarcopenia include its
diagnostic algorithm. Bonsignore [17] and Marmorato et al. [18] believe that the use
of muscle ultrasound is also potential in this area and is largely based on pioneering
studies in which muscle mass and its architecture are evaluated using this method in
healthy subjects and respiratory patients.
1.3 Sarcopenia indexes in CRDs
1.3.1 Body mass index (BMI)
Body mass index (BMI) should be mounted on a wall using standard hospital
calibration scales, because these parameters are very useful and fruitful in respira-
tory treatment as an indicator of health status. BMI is calculated as body mass (kg)
divided by squared body height (m2). However, this mostly applies to patients with
severe COPD where an increasing BMI is linearly associated with better survival,
while in patients with mild to moderate COPD the lowest mortality risk occurs in
normal to overweight or weight loss in these patients. The World Health Organiza-
tion criteria were used to classify the subjects as low-weight (BMI < 18.5), eutro-
phic (18.5 < BMI ≤ 24.99), overweight (25 ≤ BMI ≤ 29.99) or obese (BMI ≥ 30.00)
[19]. This index and division for respiratory patients can also be cited and so for all
population recognized. The biggest problem with BMI is that when patients with
chronic respiratory disease have a normal weight, they are unable to recognize the
percentage of the muscles of this patient, which is the main cause of her movement
and activity, and in this situation, we need to use more precise equipment the body
composition by BIA (Bioelectrical Impedance Analysis), including the percentage of
muscle, fat, bone, lean mass, hole body mass, is more accurately measured, and this
can be useful in a more accurate diagnosis of sarcopenia in these patients [20].
1.3.2 Skeletal muscle index (SMI)
One of the most important indicators of sarcopenia in chronic respiratory
patients is the skeletal muscle index (SMI), which is measured by factors such as
age, height, weight, ethnicity, gender, and BMI in a valid and reliable formula, and
its rate in an evaluation table according to gender and age is measurable. This index
is the most important factor in the diagnosis of sarcopenia in chronic patients,
especially in patients with respiratory disease. SMI is calculated as a function of
weight and height as follows: (height [m]_0.244_body mass) + (7.8_height) +
(6.6_gender) – (0.098_age) + (ethnicity – 3.3). The SMI index is then calculated by
dividing an individual’s SMI (kg) by his or her height squared (m2). This indicator
can be used as the main factor in the diagnosis of a respiratory patient with
sarcopenia [21].
The gold standard of research for evaluating sarcopenia relies on complete
techniques, cross-sectional imaging, a non-functional, and more structured
approach to routine care. A more practical alternative indicator of lumbar muscle
density in L3 using a normalized computed tomography (CT) is called skeletal
muscle index (SMI). While evidence suggests that decreased lumbar SMI is associ-
ated with adverse clinical outcomes, such as deaths in the lung or colorectal cancers,
little research has investigated how this measure of sarcopenia relates to dyspnea or
decreased exercise tolerance. Although lung cancer patients and respiratory patients
often use chest CT scans as part of their care, fewer respiratory patients receive
lumbar scans. This limits the ability to evaluate sarcopenia using the lumbar SMI
and therefore requires the discovery of the quadriceps SMI instrument as a more
accurate sarcopenia measure. Besides, the measurement of thoracic skeletal muscle,
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which is involved in breathing work, may be associated with better breathing and
better functional capacity [22, 23].
Spencer [24] and Soicher et al. [25] did not report a significant relationship
between SMI and breath intensity. There was also no significant relationship
between SMI, respiratory rate, and 6MWT interval. Similarly, the Cox proportional
hazards model [25] did not show a significant relationship between SMI and manual
weakness. Finally, using this technique, 50 patients with eligible Lumbar Scan
diagnoses were identified and found similar results. Over time, the SMI has gradu-
ally declined unacceptably. There was a significant relationship between Pearson
correlation coefficients in lumbar and thoracic scans in this issue. Their findings
suggest that the definition of SMI-based sarcopenia is not associated with severe
breathing, exercise capacity, or survival in a small sample of patients with advanced
lung cancer. The strengths of the present study include a population with comple-
mentary sarcopenia features, severe breathing and exercise tolerance, and robust
exploratory analysis. Despite the negative results, they demonstrated the feasibility
of measuring sarcopenia using SMI. They were limited by the small sample size and
missing data. Whereas a larger sample provides more power to detect significant
index correlations. They used CT scans performed in the usual stages of care, which
may not meet the exact criteria of future research. Changes in the quality of CT
scans may result in indeterminacy. Besides, it cannot illuminate the severity of
respiratory illnesses and other complications present in diagnostic models to poten-
tially improve the accuracy of treatment models in respiratory patients [26, 27].
1.3.3 Anthropometric indexes
For a more accurate diagnosis of sarcopenia, according to scientific reports,
anthropometry and measurement of body sections such as arms, trunk, pelvis, and
legs are important parameters for measuring anthropometry in the diagnosis of
sarcopenia. A chronic respiratory patient must be normal, since muscle atrophy will
be directly related to muscle weakness and general weakness of the body, and
ultimately lead to a decrease in the physical activity of the patients. In these condi-
tions, the quality of life of the patients is compromised and they are not able to
continue their normal life and eventually the mortality rate increases [28].
1.4 Pulmonary rehabilitation in CRDs
The results of scientific predictions show that pulmonary rehabilitation (PR)
reduces frailty but there is little evidence of this intervention in this area. PR has
been shown to significantly improve patients’ symptoms and quality of life in
patients with respiratory disease. Public daily activities can relieve shortness of
breath and fatigue, as well as increase exercise tolerance, and affect patients’
self-control and feel it. Recently, studies have shown that the lack of association
between fat mass and the 6-minute walk test (6MWT) is one of the general consid-
erations in assessing COPD patient status longitudinally to identify alternatives in
predicting the future of these patients. In addition to improving respiratory and
functional symptoms, pulmonary rehabilitation programs also target elements such
as weakness, depression, inactivity, and fatigue [29, 30].
Jones et al. [31] investigated the interaction of sarcopenia index in patients
with COPD and response to pulmonary rehabilitation. In this study, 622 elderlies
and middle-aged COPD patients were included in the study. An immediate cohort
study was followed over four years of pulmonary rehabilitation in patients with
weakness and COPD. The pulmonary rehabilitation program consisted of an 8-week
outpatient and 2-time weekly and home-based one-time training program.
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The sessions consisted of 1:15 h of training, with 25.6% of participants in the
pulmonary rehabilitation program being a weakness (according to the Freud phe-
notype model), while only 10% of the participants did not meet any of the weakness
criteria. Significant improvements have been reported in a variety of areas includ-
ing the Dyspnea MRC scale, manual dynamometer, chronic fatigue and anxiety,
emotional scores, hospital stress, and depression shuttle score and walking test. All
of these parameters are related to sarcopenia indices in respiratory patients.
Sarcopenia has increased with age and the World Initiative Index for Obstructive
Pulmonary Disease. It can be clearly stated that disorders of the skeletal muscle are
more important in evaluating sarcopenia in chronic respiratory patients [32, 33]. In
the event of any disruption to the structure and function of the large musculoskel-
etal system of the body, especially the lower limbs and the foot, which are the main
cause of movements, there will be widespread changes in weight loss, overweight,
body composition, body diameter, water, fat, muscle percentage. Ultimately, the
amount of physical activity a patient has directly related to their muscles [34, 35].
2. Main objective
The main objective of this study was to evaluate the relationship between rectus
femoris phenotype and femoral bone mineral density as the main indicators of
sarcopenia in chronic respiratory patients following a pulmonary rehabilitation
protocol with a cardiopulmonary exercise test approach (ERS/ATS instructions).
The effect of this relationship on lung function and muscle structure in these
patients has also been investigated.
3. Methodology and materials
3.1 Ethics and Research Committees
This study has been approved by the Ethic Committee and the Research
Committee Parc Sanitari Sant Joan de Deu, in the research group: “Clinical and
epidemiologic research on high-prevalence disorders” (Faculty of Medicine at the
University of Barcelona). All patients who volunteered before signing an informed
consent form had all information about the goals, techniques, possible outcomes,
and therapeutic processes in the pulmonology, rehabilitation, and radio diagnostics
departments. Also, all patient information without personal access is completely
confidential and is for the sole purpose of this research (Figure 1).
3.2 Study design
Figure 2 shows the general design of the study as a work plan of the study.
The patients had asthma, COPD, bronchiectasis and obesity (randomly, 38 men and
women selected from the chronic respiratory community at the hospital) with a
dyspnea score ≥ 2 in MRC index. We evaluated the general characteristics of the
patients including: gender, age, weight, height, BMI and clinical history, spirometry
of lung function, at the pulmonology and rehabilitation departments. Then, they
were referred to the Radio diagnostic department to perform a DEXA scan test to
evaluate the femoral bone mineral density (T-score and Z-score) and ultrasonogra-
phy on the rectus femoris quadriceps muscle (cross-sectional area, distance and
circumference). They performed a 4-month long term a pulmonary rehabilitation
protocol (Table 1), which included: exercise tests—incremental and constant,
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12 weeks, 3 times a week, duration of each session was 1 h 15 min. Breathing
techniques, respiratory muscle training and self-management, (ATS-ERS guide-
lines, 2013–2015) were conducted with the supervision of specialists. Following the
pulmonary rehabilitation protocol, all patients performed assessments as post-
rehabilitation like pre-rehabilitation, according to the protocol study. Main inter-
vention: cardiopulmonary exercise tests (CPET) was developed by American Tho-
racic Society in 2003 [36] as the gold standard with validity and reliability to study a
patient with limited level of exercise and to evaluate improvement of respiratory
patients before and after pulmonary rehabilitation protocol.
3.3 Statistics
Descriptive statistics (frequency, mean values  standard deviation, variance...)
was used to analyze the variables of clinical history and health status indexes in
Figure 1.
Group sessions of chronic respiratory patients in Department of Rehabilitation at Parc Sanitari Sant Joan de Deu.
Figure 2.
Work plan concept (pulmonary rehabilitation protocol).
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preliminary characteristics (age, gender, height, weight, BMI, patients, smoking,
diabetic, hypertension, depression and crisis).
Differences between pre- and post-rehabilitation protocol in assessments of
spirometry, skeletal muscle index (SMI), femur bone mineral density and ultra-
sound rectus femoris muscle in quadriceps, were analysed using t-Student of one
sample T-test, independent sample T-test and paired sample T-test. Evaluation of
correlation between rectus femoris phenotype parameters and femur bone mineral
density indexes was done using Pearson correlation in bivariate method of SPSS.
In this study we received report analyzed from department of electrodiagnostic
on rectus femoris muscle by ultrasound report and femur bone mineral density by
DEXA scan that we used of these figures in assessments of rectus femoris phenotype
and FBMD parameters.
We evaluated all of the variables analysis by SPSS version 21.0 software (SPSS
Inc., 2012, Chicago, IL, USA) and Excel 2016 (office 2016) to be used for database.
Statistical significance was set at P < 0.05.
4. Results
4.1 Measurement preliminary characteristics and clinical history
Table 2 shows that, most of the patients had COPD and the prevalence was
higher in men. We found significant changes in chronic respiratory patient’s BMI
No Exercise Instructions Time
(min)
1 Warm up Walking, rotation of joints in upper limbs and lower limbs, rotation






The test began with a 1-min warm-up period at minimal cycle
ergometer load (15 W), with 5- to 10-W increases every 2 min that
were individually selected to maintain the period of load increase in
the 8-to-12-min range. 1-min active recovery using minimal cycle
ergometer load followed the peak load interruption and was followed
by a 6-min passive recovery. Treadmill test is special for patients that
they have knee osteoarthritis and must be attention to standards
indexes in exercise program and initially, the walking speed is very
slow for warm up, but each minute the required walking speed
progressively increases. Total, time for treadmill test 6 min
25
3 Light dumbbell Repetition of light dumbbell (50% resistance) for improvement of
endurance muscle in major muscles, e.g., shoulders, back, low back,
pectoral muscles, trunk sides, quadriceps, leg muscles that more used




RMT may consist of inspiratory muscle training (IMT) or expiratory
muscle training (EMT) or a combination of both includes: (1)
diaphragmatic reeducation, (2) profound inspiration, (3) inspiratory




(1) Pursed-lips breathing, (2) diaphragmatic (abdominal/belly)
breathing, (3) better breathing tip: stop, reset, continue
5
6 Cold down Light walking, deep breathing, stretching of muscles that more used in
exercise program, e.g., breathing muscle, major muscles, peripheral
muscles that employed during exercise and fresh mind 1 min
10
Table 1.
Cardio-pulmonary exercise protocol (study protocol) in chronic respiratory patients.
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We evaluated all of the variables analysis by SPSS version 21.0 software (SPSS
Inc., 2012, Chicago, IL, USA) and Excel 2016 (office 2016) to be used for database.
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Cardio-pulmonary exercise protocol (study protocol) in chronic respiratory patients.
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from 30  1.06 (kg/m2) before the rehabilitation protocol to 29  1.00 (kg/m2)
after that and we also observed weight loss in all respiratory patients. Regarding the
clinical history of patients, we can see that 42% of patients have a history of
hospitalization and the average rate of smoking in all of them is 15  3.0 years.
A remarkable point in this study, which is very important for respiratory patients,
is the amount of oxygen consumed via O2 capsulate at home which significantly
decreased special in COPD and obesity patients (from 30% to 14%) after the
pulmonary rehabilitation protocol (Figure 3). Table 2 also shows that 50% of the
patients had knee arthritis, 21% cardiovascular disease, 31% depression, 31%
diabetes, and 14% hypertension. Finally, the rate of respiratory crisis with high
intensity decreased significantly (P < 0.05) from 14% to 3% after the pulmonary
rehabilitation. We observed that in all clinical and general health factors, chronic
respiratory patients recovered, presenting improvement in general health and
clinical conditions.
4.2 Measurement of correlation between FBMD and RFMTCSA
In the analysis of Pearson’s correlation r = 0.607 between T-scores and Z-score in
femur bone mineral density (FBMD) and Rectus femoris Mid-Tight Cross Sectional
Area (RFMTCSA) in pre-rehabilitation, there is a significant correlation between
the variables (P < 0.001). In the analysis of the Pearson’s correlation r = 0.910 in
post-rehabilitation between T-score and Z-scores in FBMD and RFMTCSA, there
have a higher significant correlation between variables than pre-rehabilitation on
P < 0.001 (Table 3). It can be said that there is a significant relationship between
FBMD and RFMTCSA after pulmonary rehabilitation protocol, and in both T-score
and Z-score of FBMD with rectus femoris phenotype in RFMTCSA significant
Figure 3.
Oxygen capsulate consumption monitored at home, h/per day, P < 0.05.
Variables One-Sample Test
M df P Lower Upper
Skeletal muscle index pre-RHB 16  32 32 0.001 28.00 36.00
Skeletal muscle index post-RHB 17  34 32 0.001 30.00 38.00
Formula: *Skeletal muscle index (SMI): (height [m] 0.244 body mass) + (7.8 height) + (6.6 sex) – (0.098 age) +
(ethnicity – 3.3).
Table 3.
T-test skeletal muscle index on chronic respiratory airway patients on P < 0.05.
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progress was observed. But in chronic respiratory patients this significant increase
was shown in Z-score higher than T-score. Also we can see that in circumference of
RFMTCSA between pre- and post-rehabilitation protocol did not have significant
change or improvement in correlation with T-score and Z-score (Figure 4).
4.3 Measurement of skeletal muscle index (SMI)
There was a significant increase in musculoskeletal index before (pre-
rehabilitation SMI, mean = 16  32) and (post-rehabilitation SMI, mean = 17  34)
after the pulmonary rehabilitation protocol and they showed positive changes after
the rehabilitation protocol P < 0.001 (Table 3).
4.4 Measurement of spirometry lung function
In the spirometry variables, we can see that most significant changes have
occurred in FEV1/FVC% (mean SEM = 40.00 7.0 vs mean SEM = 35.00 7.0)
Figure 4.
Correlation between T-score and Z-score of the femur bone mineral density and rectus femoris cross sectional
area in phenotype quadriceps, at P < 0.001.
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and FEV1/FVC ltr (mean  SEM = 27.00  5.0 vs mean  SEM = 25.00  5.0). In
variable of FEV1 % (mean  SEM = 51.00  2.0 vs mean  SEM = 52.00  2.0), we
saw that there was a significant change in pre- and post-rehabilitation protocol that
cannot be considered as acceptable positive changes but can be seen in the effec-
tiveness of the pulmonary rehabilitation protocol on spirometry variables in chronic
respiratory patients (P < 0.001) (Table 3). Also, we reported that in bronchitis
patients we have had highest significant in FEV1/FVC % and obesity patients had
more significant in FEV1 %. Asthma patients had increase significant in FVC perc in
pre- and post-rehabilitation protocol (Figure 5).
5. Discussion
In this study, we concluded that by comparing bone, muscles as the main
indicators diagnosis of sarcopenia in chronic respiratory patients, we find that
rectus femoris is the most effective quadriceps muscles in the diagnosis of
sarcopenia. RFMTCSA, Distance, and Circumference muscle parameters, and
DEXA scan at Z-score and T-score of femur bone density after patients’ rehabilita-
tion protocol were significantly different. In other words, in all the ultrasound
indices of the rectus femoris muscle and the DEXA scan data of the femur, we
found positive incremental data. With these considerations in mind, it can be said
that although patients with normal daily activities can control the main indicators of
sarcopenia, they can improve the quality of life and improve the outcomes of all
major muscular and bone markers. Muscle function, lung function, and exercise
capacity require a comprehensive pulmonary rehabilitation program that can help
to prevent muscle weakness and degeneration, as well as reduce important bone
mineral density such as the femur and ultimately their mortality rate. We conclude
that not all factors are necessary to accurately determine the severity of sarcopenia
in patients with chronic respiratory disease, and if specialists consider rectus
femoris ultrasound and femur bone DEXA as the most important factors for
maintaining body stability, they can monitor the latest status of respiratory patients
with sarcopenia and more accurately diagnose the health status and mortality of the
chronic respiratory patients.
We also examined whether spirometry indices are actual measurements and
better predictors of whether CRDs patients develop sarcopenia than the GOLD
Figure 5.
Mean different between spirometry parameters (liter, %) in asthma, bronchiectasis, COPD and obesity patients
in pre- and post-pulmonary rehabilitation protocol.
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staging of the disease. Sarcopenia and obesity have direct effects on lung function
values and we recommend that both elements should be evaluated in all respiratory
patients. We found that respiratory patients with sarcopenia had lower T-score
BMD, which means a higher prevalence of osteoporosis. Also, the presence of
sarcopenia was significantly associated with an increased risk of osteoporosis and
low BMD in both low- and high-weight patient groups. Therefore, in evaluating
patients with CRDs, the presence of sarcopenia should be considered an indepen-
dent risk factor for low BMD.
Lung function is a stronger independent predictor compared to body composi-
tion parameters. Taken together, these parameters are not only useful for assessing
breathing and the treatment process, but are also a potential surrogate for patients’
physical function. Some of the limitations of our study deserve attention. The
relatively small size of our samples, which may be in line with the study hypothesis,
may limit our findings. But our conclusion holds for a whole population, but may
not be entirely true for a population with more prevalent respiratory disease. This
does not mean that the conclusion is highly generalizable. We evaluated body
composition by DEXA, a method widely accepted in scientific research, but not by
the "gold standard" for patients. Besides, we define sarcopenia based on purely
quantitative parameters of body composition, but we are also able to provide infor-
mation on the qualitative dimension of sarcopenia. Finally, the cross-sectional
design of the study allowed for the creation of a causal sequence among the rela-
tionships studied. Body composition may be an important determinant of physical
function in elderly respiratory patients. This research is needed to confirm these
observations on larger samples to improve our understanding of the factors
influencing physical function in a more complex population such as chronic
respiratory patients.
In a study similar to our study, Xiong et al. [13] mentioned the intensity of echo
(EI) was significantly increased by ultrasonography in rectus femoris at all stages of
the GOLD standard following the pulmonary rehabilitation protocol for COPD
patients. However, the cross-sectional area of rectus femoris (RFcsa) in GOLD
standard decreased. This suggests that changes in EI Rectus femoris may occur
earlier in muscle size in patients with COPD. EI was not associated with age, BMI,
and airflow obstruction in our patients. These results show peripheral muscle func-
tion in patients with COPD, whose strength and size of the quadriceps are lower
than in normal subjects. Some researchers have focused on the relationship between
quadriceps strength and thickness with lung function in respiratory patients, which
can be assessed using muscle ultrasound [37]. In another study, the effect of small
and large muscular disorders was examined on admission, especially in quadriceps.
Rongchang [9], reported expected gender differences in quadriceps muscle for
COPD and control groups and similar data were also reported, indicating that in
quantifying quadriceps performance compared to controls, sex and age, mean
QMVC declined 47% and 45% in men and women; a more severe decrease than
previously reported, indicating a significant impairment of quadriceps strength in
COPD patients. In other studies, the effects of small and large muscular disorders,
especially in the quadriceps, was related to the time of hospitalization.
In the study Greening et al. [4] measured the level of quadriceps (Qcsa) as a
marker of muscle mass. This method has previously been confirmed in computed
tomography, Qcsa as well as X-ray absorptiometry in people with COPD and is
useful for patient evaluation in acute conditions and under the need of patient
effort. Regarding the hospital admission, the mean daily proportion of patients with
respiratory distress and disorder was different in the small and large muscle groups.
This indicates that skeletal muscle function is crucial not only for hospital admission
but also for the severity and duration of hospitalization.
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5.1 Response to pulmonary rehabilitation (PR)
As previously mentioned, in patients with chronic respiratory airway disease,
sarcopenia is one of the major problems of these patients, which gradually causes
atrophy and weakness in their muscles, ultimately reducing physical activity and
severely affecting their quality of life. If they do not participate in pulmonary
rehabilitation and physical exercise, they will experience general weakness and a
gradual increase in mortality. Therefore, it can be said that the major part of
sarcopenia is due to musculoskeletal disorders, which include their structure and
physical movement, and should be a top priority in these patients’ pulmonary
rehabilitation programs. In this study, we aimed to investigate sarcopenia factors in
chronic respiratory patients that revealed a significant increase in ultrasound on the
rectus femoris cross-sectional area (RFMTCSA) and rectus femoris peripheral as
well as on DEXA scans on femoral bone mineral density (FBMD) at the Z-score, in
fact, rectus femoris muscle peripheral and femur bone density were among the
factors that had positive effects on factors such as leg muscle strength, quality of
life, lung function and exercise capacity. Regular rehabilitation programs have
shown that they have progressed gradually, but their sarcopenia has dropped
significantly, requiring regular, long-term pulmonary rehabilitation.
6. Conclusions
6.1 Our programme of pulmonary rehabilitation improved
• Parameters of quadriceps muscle specially in COPD patients, RFMTCSA in
pre-rehabilitation = 1.73 and post-rehabilitation = 2.38.
• The rate of femur bone mineral density (FBMD) increased after the pulmonary
rehabilitation protocol.
• We found that there was a significant reduction in BMI and crisis indicators in
respiratory patients, and there was significant difference in the low rate
consumption of oxygen capsule.
• Correlation between RFMTCSA quadriceps and FBMD factors significantly
increased after the pulmonary rehabilitation protocol.
• Significant positive changes were observed in FEV1/FVC its, FEV1/FVC perc,
FVC its, we have had same record scales before and after the pulmonary
rehabilitation protocol.
• Also, patients were also less likely to use capsulate oxygen at home and we
found that home exercises and breathing techniques had a significant impact
on maintaining the effects of the pulmonary rehabilitation protocol and
enhancing self-esteem and confidence in the daily activities of the respiratory
patients, and to the extent that they did so long after the rehabilitation
protocol, exercises, and breathing techniques continued at home.
I hope this research will shed some light on the complications of sarcopenia in
chronic respiratory patients and help to reduce the problems of older patients with
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Environmental media majorly connotes abiotic components of the natural 
environment, namely, air, water and soil. Pollution to these media has resulted to a 
great deal of respiratory defects. Epidemiologic studies conducted in the U.S. and 
abroad provide evidence of associations between short and long-term exposure to 
fine particles in the air and both decrements in lung function growth in children 
and increased respiratory symptoms. Particles deposited in the respiratory tract in 
sufficient amounts induce lung inflammation, which has been demonstrated in both 
animal and controlled human exposure studies. More recently, the International 
Agency for Research on Cancer (IARC) also conducted an evaluation on the carcino-
genicity of outdoor air pollution in the respiratory tract, including particle pollution, 
and concluded that both are Group I agents (carcinogenic to humans). Air pollution 
has been given great priority as a causal factor for respiratory defects; meanwhile 
dust particles from contaminated soil could also cause a great havoc. Moreover 
polluted water is also a major causal pathway. According to world health organiza-
tion (WHO) 80% diseases are waterborne. Though water is an important natural 
resource used for drinking and other developmental purposes in our lives but health 
risk associated with polluted water includes different diseases in which respiratory 
diseases are the major ones. Bacterial, viral and parasitic diseases are spreading 
through polluted water and affecting human health. Poliomyelitis virus is respon-
sible for poliomyelitis, sore throat, fever, nausea, which are all due to polluted water.
Keywords: air, water, soil, lung inflammation, cancer, nausea
1. Introduction
Defect is any abnormality or imperfection that is capable of impairing quality, 
function or utility [1]. A respiratory defect is therefore any impairment in the vital 
function or utility of the respiratory system caused by abnormalities (congenital 
or induced) in one or more of the respiratory organs. The major organs of the 
respiratory system are the nose and nasal cavity, larynx, pharynx, bronchi, alveoli, 
trachea and the lungs. They function primarily to provide oxygen to body tissues for 
cellular respiration, remove the waste product carbon dioxide, and help to maintain 
acid-base balance [2]. Due to the anatomy of the respiratory tract, it is constantly 
exposed to microbes, which is why the respiratory system includes many mecha-
nisms to defend itself and prevent pathogens from entering the body.
Lungs are the powerhouse of the respiratory system. Through inhalation oxygen 
is brought into the body with and exhalation rids the body of carbon dioxide. Harm 
to the lungs can result from presentation to numerous things noticeable all around, 
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for example, allergens, lethal substances, metals, and molds. Research has indicated 
that long term introduction to air contaminations can influence the development 
and improvement of the lungs, and increment the danger of creating asthma, 
emphysema, and other lung illnesses.
The NIEHS-sponsored Harvard Six Cities Study found a significant relation-
ship between introduction to fine particle air pollution and early deaths. Likewise, 
perhaps the greatest risk to lung wellbeing is tobacco smoke, containing many 
poisons, for example, nicotine carbon monooxide, tar, arsenic, cadmium, methane, 
etc. [3]. Respiratory disease is a common and significant cause of illness and death 
around the world. The most common cause of illness in children in developed 
countries and a leading cause of death in children in developing areas are diseases of 
the lung and airways. According to the Centers for Disease Control and Prevention 
(CDC), chronic obstructive pulmonary disorder (COPD) is the fourth leading cause 
of death in the United States. Its prevalence increases with age. Men are more likely 
to have the disease, but the death rate for men and women is about the same. In 
another research conducted in the United States in 2010, it was discovered about 
6.8 million visits to the emergency division were for respiratory issues from patients 
younger than 18. About one-seventh of the United Kingdom population is affected 
by some type of persistent lung disease, most commonly COPD, which incorporates 
asthma, persistent bronchitis, and emphysema. There are various ways by which 
respiratory disorders can be classified: it could be based on
1. The organ or tissue involved
2. Pattern of signs and symptoms associated with the disease
3. Causal factor of the disease
Generally, respiratory disorders can be classified into these areas;
• Obstructive respiratory conditions are usually characterized by obstructed 
airflow inflamed and easily collapsible airways. Examples are asthma, bronchi-
tis, emphysema, bronchiectasis, etc.
• Restrictive respiratory conditions these disease restrict lung expansion result-
ing in reduced lung volumes, either because of an alteration in lung paren-
chyma or because of a disease of the pleura (e.g., fibrosis, sarcoidosis, alveolar 
damage, pleural effusion).
• Vascular diseases. They are diseases that affect the blood vessels from the heart 
to the lungs. They are of two major types: pulmonary embolism and pulmo-
nary hypertension.
• Environmental and occupational respiratory “diseases.” These respiratory 
defects are caused by harmful particles, mists, vapors, or gases that are 
inhaled, in the surroundings where people live and usually while people work. 
Various sorts of particles elicit various reactions in the body. For instance, par-
ticles like animal dander could cause unfavorably susceptible responses, like 
hay fever-like symptoms or a kind of asthma. Different particles cause hurt not 
by activating hypersensitive responses, however by being harmful to the cells 
of the aviation routes and air sacs in the lung. A few particles, for example, 
quartz residue and asbestos, may cause incessant aggravation that can prompt 
scarring of lung tissue (aspiratory fibrosis). Certain lethal particles, for 
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example, asbestos, can cause lung malignant growth, especially in people  
who smoke, or cancer of the lining of the chest and lung (mesothelioma),  
(e.g., pneumonia, tuberculosis, asbestosis, particulate pollutants) [4, 5].
2. Overview of the environment and its various components (media)
The environment can be defined as all that which is external to the individual 
host. It can be divided into physical, biological, social, and cultural factors, any or 
all of which can influence health status in populations [6]. In other words environ-
ment refers to those things that surrounds living beings and affect their lives. The 
environment is man’s basic life support system. It provides the air we breathe, the 
water we drink, the food we eat and the land where we live.
The four major components of environment include lithosphere, hydrosphere, 
atmosphere and biosphere, corresponding to rocks, water, air and life respectively.
Lithosphere is the outermost layer of earth called crust, consisting of various 
minerals, it is where we have the rocks and soil. It is about 100 km in depth, and 
is found on both land and seas. The principal component of lithosphere is earth’s 
tectonic plates.
Hydrosphere, covering 70% of earth’s surface, involves all the varieties of water 
bodies on earth such as seas, oceans, rivers, lakes, lakes, streams, etc. 97.5% of water 
found on earth is in the seas as salt water. Just 2.5% of water on earth is freshwater. 
Out of this, 30.8% makes up the rivers, repositories, and lakes and is easily acces-
sible to man.
Atmosphere is the gaseous, envelope-like material encasing the earth. It is unique 
to the earth because its abundance of oxygen (20.95%) which is vital in supporting 
life on earth. other constituents of the atmosphere includes 78.08% nitrogen, 0.93% 
argon, 0.038% carbon dioxide, and trace elements like, hydrogen, helium, noble 
gases and water vapor.
Biosphere refers to all the regions on Earth where life exists. The ecosystems that 
support life could be in soil, air, water, or land.
3. The environment and health
The environment we live in is a major determinant of our state of health, from the 
rural zones to thick urban communities, the sort meals we eat and water we drink, 
places we live to the spots we work, and hence harm to our indigenous habitat, like-
wise brings about harm to human wellbeing. Factors, like inaccessible, safe drinking 
water and sanitation, air pollution and changes in climatic conditions contribute to 
23% of all deaths globally and 36% of all deaths among youngsters between the ages 
of 0 and 14. It is estimated that 1.8 billion individuals get drinking water from fecally 
contaminated water sources and 2.5 billion individuals live without essential sanita-
tion facilities, increasing the rate of diarrheal infections, malnutrition and deaths. 
Insufficient water for hygienic purposes, consumption of unsafe water and absence 
of access to sanitation together makes up about 88% of deaths from diarrheal 
diseases, resulting in 11% of mortality of kids younger than 5 [7].
Health impacts associated with damage to our environment are numerous and 
diverse ranging from diarrheal and vector-borne diseases to respiratory diseases, 
ischemic heart disease and stroke to mental health impacts of extreme weather 
events, failing livelihoods, conflict and displacement [8]. This therefore implies 
that in order to reduce the incidence of disease more attention needs to be paid to 
 reducing the environmental causes such as:
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for example, allergens, lethal substances, metals, and molds. Research has indicated 
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of 0 and 14. It is estimated that 1.8 billion individuals get drinking water from fecally 
contaminated water sources and 2.5 billion individuals live without essential sanita-
tion facilities, increasing the rate of diarrheal infections, malnutrition and deaths. 
Insufficient water for hygienic purposes, consumption of unsafe water and absence 
of access to sanitation together makes up about 88% of deaths from diarrheal 
diseases, resulting in 11% of mortality of kids younger than 5 [7].
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Poor air quality: about 3 billion people depend on wood, charcoal, animal 
compost, and crop waste as fuel for the supply of energy in households. Fifty to 
seventy percent of Africa’s populace cooks with solid fuel, majorly exposing women 
and children to massive quantities of pollutants, in various concentrations, pos-
ing considerable health risks to humans, hence increasing the risk of diseases like 
pneumonia and chronic respiratory disorders on such exposures.
Poor sanitation diseases such as diarrhea result from poor sanitary conditions 
and unsafe water and are responsible for the deaths of 1.8 million people every year 
amounting to an estimated 4.1% of the total DALY global burden of disease. 88% of 
this disease burden is attributable to unsafe water supply, poor sanitation and poor 
hygiene practices. Provision of safe drinking water and sanitation are important 
measures of improvement.
Poor landscape and urban land management poor landscaping and lack of urban 
and regional planning contribute to overpopulation and overcrowding. This will 
increase the spread of infectious diseases, favor the proliferation of pest, poses a lot 
of pressure on the basic amenities and infrastructure, increased areas of stagnant 
water and thereby increasing the risk of malaria. Across the globe, about 30 million 
cases of malaria are being recorded yearly, leading to over a million deaths, with 
approximately 90% of these deaths occurring majorly among young children in 
Africa. Malaria makes up 10% of Africa’s overall disease burden and is the main 
cause of death among children under the age of five. Africa bears over us$ 12 billion 
in lost GDP yearly due to malaria.
Overexploitation and degradation of natural resources: a major factor contribut-
ing to food insecurity is over exploitation and degradation of natural resources, 
it reduces the capacity of the land to produce crops and sustain livestock. The 
resultant effect of food shortage is malnutrition and in worst cases, starvation. 
Asides reducing immunity to other diseases, severe cases of malnutrition also causes 
stunting in children and hinders healthy development. According to World Health 
Organization, across the globe, one in seven people are affected by hunger. Also, of 
the 10.9 million child deaths each year, half is attributable to malnutrition+ [7].
4. Air-induced respiratory disorders
Air is a mixture of gases comprising the atmosphere, living things requires air 
for their existence. Thus the quality of air we breathe in is a vital indicator of our 
state of health. When we breathe in polluted air, the pollutants get inhaled deep 
into the lungs, resulting in serious harm to the respiratory tract. Polluted air can 
set off new cases of asthma, worsen existing cases of respiratory diseases and 
trigger the development or advancement of chronic illness including lung cancer, 
chronic obstructive pulmonary disease, and emphysema. Air pollutants also have a 
considerably adverse effect on lung development, thus, increasing the vulnerability 
for developing lung diseases in the long run [9]. Burning of wood, animal waste, 
and crops (biomass fuel) is an important source of particulate matter indoors in 
developing countries, Secondhand smoke is also an important source of indoor air 
pollution [10]. Air pollution-related lung disease increases the risk of heart and 
blood vessel disorders and may increase the risk of lung cancer. Long-term exposure 
to air pollution may increase respiratory infections and symptoms of respiratory 
disorders (such as cough and difficulty breathing) and decrease lung function.
Ozone, a primary air pollutant and basic constituent of smog, is a strong lung 
irritant. During the year, levels are noticeably higher during summer likewise in 
contrast with other period of the day, ozone levels tend to be higher, late in the 
morning and early in the afternoon. Short-term exposures can cause breathing 
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difficulties, chest pain, and airway hyperactivity. Participating in outdoor activities 
on days when ozone pollution is high can increase the risk of developing asthma 
among children. Long-term exposure to ozone causes a small, permanent decrease 
in lung function. When fossil fuel that are high in sulfur content are burnt, they 
acidic particles called sulfur oxides, which are deposited in the upper respiratory 
tract and can cause constriction and irritation resulting in increased risk of chronic 
bronchitis and symptoms like breathing difficulty. Particles affect the lung in vari-
ous ways, depending on their primary material. Particles of the same material also 
may have different effects depending on their size and shape. Variation in environ-
mental conditions and location affects the level of pollutants in the air. For instance, 
on warm and humid days, ozone tends to remain in the air. Carbon monoxide levels 
also tend to be high during peak periods when many commuters drive to or from 
work. The Air Quality Index is utilized to convey how polluted the air is at a given 
point in time. Individuals, particularly those with heart or lung disorders, can 
utilize the Air Quality Index to manage their choice of outdoor activities on days 
when pollution levels are high [10].
AQI values Air quality condition
0–50 Good
51–100 Moderate





Adapted from US Environmental Protection Agency: Air Quality Index: A guide to air quality and your health. 
Research Triangle Park, NC, 2009.
Air Quality Index.
Children are more vulnerable to the impacts of air pollution. They inhale 
through their mouths, bypassing the sifting impacts of the nasal entries and permit-
ting pollutants to travel further into the lungs. They have a larger lung surface 
area comparative with their weight and breathe in generally more air, compared 
to grown-ups. Children also spend more time outdoors especially in the afternoon 
and throughout the summer months when ozone and other pollutant levels are at 
their peak and may disregard early indications of impact of air pollution such as, 
an asthma exacerbation leading to severe attacks. A combination of these with the 
adverse impact of some pollutants on lung development and the immaturity of 
children’s enzyme and immune systems that detoxify pollutants, results in series of 
factors that contribute to children’s increased sensitivity to air pollutants [9].
Asthma is a chronic disease which affects the bronchi and bronchioles of the 
lungs characterized by inflammation and narrowing of the airways, it causes a 
sensation of tightness in the chest, shortness of breath, wheezing, and coughing. 
Over 20 million people in the U.S., including six million children now gasp for 
breath due to asthma [9]. Asthma triggers are numerous and vary; dust, smoke, 
pollen, and volatile organic compounds are examples of asthma triggers. Primary 
pollutants such as ozone, carbon monoxide, sulfur dioxide, and nitrogen oxides are 
also outdoor triggers.
Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis and 
emphysema. Chronic Obstructive Pulmonary Disease (COPD) is an irrevers-
ible condition caused by exposure to pollutants that produce inflammation, and 
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compost, and crop waste as fuel for the supply of energy in households. Fifty to 
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difficulties, chest pain, and airway hyperactivity. Participating in outdoor activities 
on days when ozone pollution is high can increase the risk of developing asthma 
among children. Long-term exposure to ozone causes a small, permanent decrease 
in lung function. When fossil fuel that are high in sulfur content are burnt, they 
acidic particles called sulfur oxides, which are deposited in the upper respiratory 
tract and can cause constriction and irritation resulting in increased risk of chronic 
bronchitis and symptoms like breathing difficulty. Particles affect the lung in vari-
ous ways, depending on their primary material. Particles of the same material also 
may have different effects depending on their size and shape. Variation in environ-
mental conditions and location affects the level of pollutants in the air. For instance, 
on warm and humid days, ozone tends to remain in the air. Carbon monoxide levels 
also tend to be high during peak periods when many commuters drive to or from 
work. The Air Quality Index is utilized to convey how polluted the air is at a given 
point in time. Individuals, particularly those with heart or lung disorders, can 
utilize the Air Quality Index to manage their choice of outdoor activities on days 
when pollution levels are high [10].
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children’s enzyme and immune systems that detoxify pollutants, results in series of 
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also outdoor triggers.
Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis and 
emphysema. Chronic Obstructive Pulmonary Disease (COPD) is an irrevers-
ible condition caused by exposure to pollutants that produce inflammation, and 
Respiratory Physiology
58
immunological response. It is characterized by narrowing of the airways. In larger 
airways, the inflammatory response is referred to as chronic bronchitis. It leads to 
tissue damage or emphysema in the tiny air cells at the end of the lung’s smallest 
passageways [9]. Emphysema is a chronic disease that causes reduction of the respi-
ratory surface due to the damage to the lung alveolar walls. It is caused mainly by 
cigarette smoking, dust, chemicals and exposure to passive cigarette smoking. The 
main symptoms of emphysema include shortness of breath and cough. Emphysema 
might lead to a loss of elasticity of the lungs.
Lung cancer in the U.S, the main cancer killer in both men and women is lung 
cancer, is frequently (and precisely) related with smoking tobacco. While that is 
valid, there are also other risk factors associated with lung cancer, along with air 
pollution. Particulate issue and ozone are also implicated in mortality due to lung 
cancer [9].
5. Occupational respiratory disorders
Occupational respiratory disorders are defined as any disorder which affects 
the respiratory system by long-term inhalation of chemicals, proteins, and dust. 
Occupational respiratory disorders might happen due to the inhalation of the 
following substances fumes from metals, smoke from burning organic materials, 
sprays of varnishes, paint, acids, and pesticides, dust from cotton, silica, coal, drug 
powders and pesticides and gases from industries. The type of occupational respira-
tory disorder depends on the environment to which the person is exposed: people, 
particularly those with other lung disorders, are at risk when they are exposed to 
air pollution in the environment or to contaminants in indoor environments. Some 
many more people are at risk of occupational asthma as a result of exposure in the 
workplace. Exposure to asbestos can cause asbestosis, mesothelioma, and asbestos-
related pleural disease. People who work with beryllium, such as aerospace workers, 
are at risk of beryllium disease. Byssinosis is prevalent among people who work 
with cotton, flax, or hemp. Coal workers and graphite workers are at risk of coal 
workers’ pneumoconiosis. Prolonged exposure to silica would result in silicosis [5].
6. Soil-related respiratory defects
Soil is a complex system of air, water, minerals, natural matter and biota that 
covers the terrestrial earth in layers over the underlying bedrock. Endogenous 
segments of soil incorporate minerogenic colloidal clay and trace elements, biogenic 
organic materials, and biota, any of which might be advantageous, impeding or 
harmful, contingent upon their relative concentrations and the exposure pathway. 
Soils are also significant source of supplements, and they go about as common chan-
nels to expel contaminants from water [11]. Notwithstanding, soils may contain 
heavy metals, chemicals, or pathogens that can adversely affect human wellbeing. 
As soil is persistently being made airborne and afterward dispersed through the air 
by the global components of climate and weather. Soil, in dust forms, can sometime 
be dispersed to great distances therefore, increasing the exposure levels of humans 
to soil particles throughout their evolutionary history, from both local and regional 
sources and potentially from almost anywhere on the planet [12].
The NIH National Institute of Allergy and Infectious Diseases also reported that 
airborne residue is the main source of environmental agents that encourage human 
allergic disorders [13]. The basis of reactions of the human immune system to 
airborne dusts has created an outcome of long term exposures, on a developmental 
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time scale to minerogenic, biogenic and anthropogenic parts that are pervasive seg-
ments of the natural history of people. The manner in which the respiratory system 
reacts to inhaled particles depends on where the molecule settles. For instance, 
irritant dust that settles in the nose may prompt rhinitis, an irritation of the mucous 
layer. Peradventure the molecules attacks the larger airways, irritation of the trachea 
(tracheitis) or the bronchi (bronchitis) might be seen (Figure 1).
The most prominent responses of the lung happen in the core of the organ. 
Particles that avoid being eliminated in the nose or throat in turn settles in the 
sacs or near the distal part of the airways. Be that as it may, if the dust quantity is 
enormous, the macrophage system can fail. Dust particles and residue containing 
macrophages accumulate in the lung tissues, causing damage to the lungs. The 
amount of dust and the types of particles involved is proportional to how severe the 
lung damage will be. For instance, after the macrophages swallow silica particles, 
they undergo apoptosis and emit harmful substances. These substances cause 
sinewy or scar tissue to form. This tissue is simply the body’s typical means of fixing 
itself. However, on account of crystalline silica so much stringy tissue and scarring 
structures accumulate so much that the lung capacity can be debilitated. The gen-
eral name for this condition for sinewy tissue arrangement and scarring is fibrosis. 
The particles which cause fibrosis or scarring are called fibrogenic. At the point 
when fibrosis is brought about by crystalline silica, the condition is called silicosis. 
Once deposited in the pulmonary alveoli, these quartz-based minerogenic silica 
particles start a fibrotic wound reaction that can in the long run lead to silicosis, 
a debilitating pneumonic condition. Extreme silicosis can additionally harm the 
immune system by impeding the ability of macrophages in the lungs to distort the 
growth of pathogenic organisms found in airborne dust, prompting a variety of 
bacterial infections [14].
An inherited hypersensitivity of the immune system to react to a specific 
ubiquitous airborne antigen or the presentation to a new aerosoled soil material 
Figure 1. 
The human respiratory tract (source: Pinterest.com).
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with cotton, flax, or hemp. Coal workers and graphite workers are at risk of coal 
workers’ pneumoconiosis. Prolonged exposure to silica would result in silicosis [5].
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segments of soil incorporate minerogenic colloidal clay and trace elements, biogenic 
organic materials, and biota, any of which might be advantageous, impeding or 
harmful, contingent upon their relative concentrations and the exposure pathway. 
Soils are also significant source of supplements, and they go about as common chan-
nels to expel contaminants from water [11]. Notwithstanding, soils may contain 
heavy metals, chemicals, or pathogens that can adversely affect human wellbeing. 
As soil is persistently being made airborne and afterward dispersed through the air 
by the global components of climate and weather. Soil, in dust forms, can sometime 
be dispersed to great distances therefore, increasing the exposure levels of humans 
to soil particles throughout their evolutionary history, from both local and regional 
sources and potentially from almost anywhere on the planet [12].
The NIH National Institute of Allergy and Infectious Diseases also reported that 
airborne residue is the main source of environmental agents that encourage human 
allergic disorders [13]. The basis of reactions of the human immune system to 
airborne dusts has created an outcome of long term exposures, on a developmental 
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time scale to minerogenic, biogenic and anthropogenic parts that are pervasive seg-
ments of the natural history of people. The manner in which the respiratory system 
reacts to inhaled particles depends on where the molecule settles. For instance, 
irritant dust that settles in the nose may prompt rhinitis, an irritation of the mucous 
layer. Peradventure the molecules attacks the larger airways, irritation of the trachea 
(tracheitis) or the bronchi (bronchitis) might be seen (Figure 1).
The most prominent responses of the lung happen in the core of the organ. 
Particles that avoid being eliminated in the nose or throat in turn settles in the 
sacs or near the distal part of the airways. Be that as it may, if the dust quantity is 
enormous, the macrophage system can fail. Dust particles and residue containing 
macrophages accumulate in the lung tissues, causing damage to the lungs. The 
amount of dust and the types of particles involved is proportional to how severe the 
lung damage will be. For instance, after the macrophages swallow silica particles, 
they undergo apoptosis and emit harmful substances. These substances cause 
sinewy or scar tissue to form. This tissue is simply the body’s typical means of fixing 
itself. However, on account of crystalline silica so much stringy tissue and scarring 
structures accumulate so much that the lung capacity can be debilitated. The gen-
eral name for this condition for sinewy tissue arrangement and scarring is fibrosis. 
The particles which cause fibrosis or scarring are called fibrogenic. At the point 
when fibrosis is brought about by crystalline silica, the condition is called silicosis. 
Once deposited in the pulmonary alveoli, these quartz-based minerogenic silica 
particles start a fibrotic wound reaction that can in the long run lead to silicosis, 
a debilitating pneumonic condition. Extreme silicosis can additionally harm the 
immune system by impeding the ability of macrophages in the lungs to distort the 
growth of pathogenic organisms found in airborne dust, prompting a variety of 
bacterial infections [14].
An inherited hypersensitivity of the immune system to react to a specific 
ubiquitous airborne antigen or the presentation to a new aerosoled soil material 
Figure 1. 
The human respiratory tract (source: Pinterest.com).
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may trigger reactions of the immune system that can bring about asthma and 
other related conditions. The scarring effect of inhaling minerogenic dust upon 
the nasopharyngeal mucosa creates an ideal environment for contamination of N. 
meningitis. Studies have shown that samples of aerosoled materials collected during 
dust events on the African continent have a host of human pathogens, including 
Actinobacter calcoaceticus, Kocuria rosea and others [15].
7. Water-related respiratory defects
Varieties of water sources can become repositories and vectors for contaminants 
related with intense and chronic lung infection. Improper sewage sanitation is an issue 
for about 40% of the world’s population, and a millions of individuals die every year 
from waterborne illnesses [16]. Polluted and filthy water is exceptionally harmful for 
living organism particularly for wellbeing of humans. It causes numerous health issues 
which can eventually lead to death if not treated on time. Inhalation of contaminated 
aerosols is the most important route of exposure leading to water-related lung disease. 
Nonetheless, dermal assimilation, dispersed marine-acquired wound infections, and 
ingestion or aspiration of water containing harmful contaminants have been related 
with pneumonic sickness also. Upper respiratory side effects are common after 
water exercises, with over 40% of recreational swimmers reporting sinus symptoms. 
Hyperemia is the suspected etiology, and indication of prolonged water exposure [17].
The center for disease control (CDC) likewise detailed the peril in swimming; 
swimmers are said to be in danger of respiratory diseases if they take in steam or 
mist from a pool or hot tub that contains harmful germs. A respiratory sickness 
brought about by the germ Legionella is one of the most reoccurring waterborne ail-
ments (drinking water and recreational water). If legionnaires’ disease develops and 
is unrecognized, mortality might be as high as 10%. Untreated lakes and streams are 
said to have been the culprit, just as public pool or hot tub [14].
8. Food-related respiratory defects
Diet and nutrition might be significant modifiable risk factors for the improve-
ment, movement and the management of obstructive lung infections, for example, 
asthma and incessant obstructive pneumonic ailment (COPD) [18]. Diet and nutri-
tion are progressively becoming recognized as modifiable contributors to chronic 
disease development and progression. Significant proof has shown the essence 
of dietary intake in obstructive lung disease, for example, asthma and incessant 
obstructive pneumonic disease (COPD) in both early life and ailment advance-
ment. This dietary example should comprise of a high admission of insignificantly 
handled plant nourishments, to be specific; organic product, vegetables, breads, 
grains, beans, nuts and seeds, low to direct intake of dairy nourishments, fish, 
poultry and wine and low intake of red meat. High intake of olive oil brings about a 
dietary synthesis that is low in soaked fat however still moderate in complete fat. Be 
that as it may, over sustenance and coming about weight are unmistakably con-
nected with asthma; however the instruments included are still under scrutiny [19].
9. Recommendation and conclusion
The ability to survey the environment and exposure must be improved upon so 
as to comprehend the impact environmental factors have on disease and to decide if 
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new ecological variables may bring about illness. Assessment methods are required 
to screen an individual’s absolute exposure to environmental factors over a lifetime 
as opposed to during a specific time span or in one circumstance. This evaluation 
could be accomplished at any rate halfway with the improvement of biomarkers 
that indicate exposure to precipitating factors from in utero to the end of life. 
Research surveys that address the multifaceted nature of the exposures are very 
likely to show the impact of environmental factors on lung infection [20].
So likewise, more discoveries should be made about the interaction between 
the individual and environment to have a better definition of at risk population. 
These efforts ought to not only distinguish most at risk population but to likewise 
consider how alterations of environmental factors could decrease the impact of 
disease. An integrative methodology will be required for these researches, alongside 
dependence on genetic technologies, bioinformatics, and complex biostatistical 
techniques. Likewise distinguishing hereditary components related with risk of 
exposure. This research could also recognize biomarkers of illness and characterize 
potential pathogenic pathways that might be focused to lessen or treat sickness [20].
Furthermore, the means by which environmental toxins influence disease 
development should be characterized. In spite of the fact that it is confirmed that 
indoor air pollution increases the danger of cardiovascular illness, so also indoor 
air contamination due to biomass smoke accumulation especially in children, the 
mechanisms by which these toxicants act are unknown [20].
Finally, to mitigate environmental lung disease, multidisciplinary research and 
public health programs are expected to decipher what is found about these toxicants 
and pathways for modifications in the environment in order to help individuals who 
are in danger of respiratory diseases. Presently, there are not too many researchers 
and clinicians who have the interest and capacity to lead environmental research. 
Hence, a significant step to improve in this field is to prepare more analysts. With 
these methodologies and the improvement of organizations among researchers 
and the general population everywhere, the role of environmental factors in lung 
disease will keep on being characterized and techniques to forestall must be imple-
mented [20].
To avoid respiratory problems with other health issues especially in work areas 
caused by exposure to dust, controls must be implemented. According to the 
hierarchy of control, the main consideration should be hazardous substances sub-
stituted with non-hazardous substances. Where substitution is impossible, other 
engineering control methods could be introduced. which include: the use of wet 
processes for the enclosure of dust-producing processes under negative air pressure 
(slight vacuum compared to the air pressure outside the enclosure); exhausting air 
containing dust through a collection system before releasing to the atmosphere; use 
of vacuums instead of brooms good housekeeping efficient storage and transport 
controlled disposal of dangerous waste; use of personal protective equipment is also 
very important, but it should nevertheless be the last resort of protection. Personal 
protective equipment should not be a substitute for proper dust control and should 
be used only where dust control methods are not yet effective or are inadequate. 
Most importantly, workers, through education and proper orientation, must 
comprehend the need to avoid the risks of dust [18].
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Furthermore, the means by which environmental toxins influence disease 
development should be characterized. In spite of the fact that it is confirmed that 
indoor air pollution increases the danger of cardiovascular illness, so also indoor 
air contamination due to biomass smoke accumulation especially in children, the 
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Hence, a significant step to improve in this field is to prepare more analysts. With 
these methodologies and the improvement of organizations among researchers 
and the general population everywhere, the role of environmental factors in lung 
disease will keep on being characterized and techniques to forestall must be imple-
mented [20].
To avoid respiratory problems with other health issues especially in work areas 
caused by exposure to dust, controls must be implemented. According to the 
hierarchy of control, the main consideration should be hazardous substances sub-
stituted with non-hazardous substances. Where substitution is impossible, other 
engineering control methods could be introduced. which include: the use of wet 
processes for the enclosure of dust-producing processes under negative air pressure 
(slight vacuum compared to the air pressure outside the enclosure); exhausting air 
containing dust through a collection system before releasing to the atmosphere; use 
of vacuums instead of brooms good housekeeping efficient storage and transport 
controlled disposal of dangerous waste; use of personal protective equipment is also 
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The history of hyperbaric oxygen therapy (HBOT) makes for fascinating  reading. 
From pneumatic chambers and compressed air baths to empirical therapeutic 
 applications during the nineteenth century, the impetus to scientific application 
of HBOT began in seeking solution for decompression sickness during various 
 construction ventures. French physiologist Paul Bert’s research was pathbreaking and 
provided a scientific explanation on the etiology of the “bends.” In 1908, JS Haldane’s 
experiments recommended staged decompression and made diving safe. In 1921, OJ 
Cunningham employed HBOT to treat hypoxia secondary to lung infections success-
fully. It was cardiac surgeon Ite Boerema who put HBOT on a solid footing with his 
open-heart surgery results in various pediatric cardiac conditions and rightly deserved 
the title of father of modern-day hyperbaric medicine. From 1937 onwards, HBOT 
research snowballed into treating a wide variety of diseases. In 1999, the Undersea 
and Hyperbaric Medical Society and Food and Drug Administration recognized the 
value of HBOT, and this led to its becoming a major tool in the armamentarium of 
 clinicians, either as a primary or adjunctive therapy for a spectrum of diseases.
Keywords: history, hyperbaric oxygen therapy
1. Introduction
Since 4500 BC, breath-holding dives for mother-of-pearl, sea sponges, and coral 
was a distinct occupation. These free divers could hold their breath for extended 
periods of time, and their work was confined to waters less than 30 m (100 ft) 
deep. It was undoubtedly a hazardous occupation, and many of them succumbed 
to decompression sickness after rapid surfacing. Persian king Xerxes the Great 
(520–465 BC) employed divers to salvage sunken goods and treasures from the 
wrecks of Greek ships he had sunk in numerous battles at sea. Some of these dives 
were recorded to depths of 20–30 m and lasting 4 minutes at a time. The ancient 
Greek historians Herodotos and Pausanias wrote about a Greek hero named Scyllias 
from Scione, who used a reed and diving capsule made from animal skins to cut the 
mooring lines of enemy ships. Pausanias even taught his own daughter Hydna to 
dive. Alexander the Great (365–323 BC), under the advice of a reputed astronomer 
named Ethicus, dived into the Bosphorus straits in a bathysphere, accompanied by 
a dog, a cat, and a rooster, after entrusting the security of the hoisting chain to his 
most loyal mistress. Taking advantage of the moment, she chose to elope with her 
lover after casting the chain into the sea, abandoning Alexander and leaving him 
to figure out his escape on his own! In 300 BC, Aristotle described the ruptured 
eardrum as a complication of undersea diving.
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While living in Venice in the late fifteenth century, Leonardo da Vinci designed 
diving suits to enable divers cut holes in the hulls of invading ships, but none seem 
to have been developed or used [1].
In 1620, Dutch inventor Cornelis Jacobszoon Drebbel (1572–1633) designed a 
wooden diving boat, sealed against water by greased leather, to travel in the River 
Thames at a depth of around 4 m, from Westminster to Greenwich. Air was supplied 
by two tubes with floats to maintain one end above water [2]. In sixteenth century 
England and France, full diving suits made of leather were used to depths of 60 ft 
with air being pumped down from the surface with the aid of manual pumps.
The first documented use of hyperbaric therapy was in 1662, when a British 
clergyman and physician named Nathaniel Henshaw used a system of organ bellows 
with unidirectional valves to change the atmospheric pressure in a sealed cham-
ber called a domicilium (Figure 1). Without any scientific rationale whatsoever, 
Henshaw claimed that high air pressures would remedy acute conditions while 
lower pressures would yield salutary results in chronic disorders. His domicilium 
therapy was touted to improve digestion and prevent lung diseases by manipulating 
ambient pressures without increasing oxygen concentrations, as oxygen was not 
discovered until nearly a century later [2].
In 1690, Edmond Halley designed a diving bell ventilated with weighted barrels 
of air sent down from the surface. Employing this device, Halley, escorted by five of 
his close friends, undertook a dive to a depth of 60 ft in the River Thames in that bell 
and remained submerged at that depth for 90 minutes. Too heavy for salvage work, 
Halley made improvements to his bell, extending his underwater exposure time to 
over 4 hours. The first deep-sea diving suit was invented in 1819 by Augustus Siebe. 
It used compressed air supplied to the helmet for ease of movement underwater.
All of these early submersibles used ambient air and were called “pneumatic 
chambers” or “compressed air baths.”
2. The era of empirical HBOT/HBO spas
Nearly two centuries later, in the 1830s, there was a rebirth of interest in 
hyperbaric medicine in France. In 1834, the French physician Junod built a 
hyperbaric chamber designed by the steam engine inventor James Watt, who was 
well-versed in pressure physics. This appliance could generate a maximum of 4 
atmospheres pressure and used to treat pulmonary afflictions using pressures 
Figure 1. 
Henshaw and his domicilium.
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between 2 and 4 ATA. Junod referred to his treatment as “Le Bain d’air com-
primé” (the compressed air bath), and claimed that it increased circulation to 
the internal organs and the brain, resulting in feelings of well-being and better 
general health.
Taberie designed a spherical pneumatic chamber made of cast iron with two 
pipes, one to provide pressure from a hydraulic compressor run by steam and the 
other to allow for ventilation. Carpet covered the floor to conceal the pipes, and it 
featured an antechamber to allow the physician to enter and exit without disturbing 
the pressure. The passage was also used to stock books, newspapers, and drinks for 
the patients (Figure 2).
Lange had a cylindrical chamber constructed out of wrought iron, designed 
to accommodate four persons. The temperature of the compressed air within 
the chamber was lowered in two ways. The first employed a stream of cold water 
directed against the force pump and the supply pipes. The second method was by 
filling a cup-shaped space at the top of the chamber with cold water and allowing it 
to cascade down the sides to soak sheets of linen and cool the air by evaporation. In 
winter the chamber was kept at a comfortable temperature by heating. The chamber 
was also provided with a device for regulating the flow of the incoming air so that 
it entered in a steady stream (instead of a succession of puffs in earlier versions) by 
a force pump. The pressure was secured, as in Tabarie’s system, by regulating the 
inflow and outflow of the air (Figure 3).
Leibig’s pneumatic chamber was located at Dianabad in Reichenhall, Bavaria, 
Germany. This pneumatic chamber had three chambers, each one capable of accom-
modating three persons. One antechamber connected all three rooms, allowing 
the physician to enter and exit without affecting the ambient pressure. The ante-
chamber also acted as a large pressure regulator, preventing the patients from being 
affected by sudden surges of pressure. A ventilation pipe through an opening in the 
ceiling provided good ventilation (Figure 4). The temperature and pressures within 
each chamber could also be individually controlled [3].
In 1837, Pravaz built the largest hyperbaric chamber in Lyon, France, to seat 
12 patients and treat patients with pulmonary conditions including tuberculosis, 
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between 2 and 4 ATA. Junod referred to his treatment as “Le Bain d’air com-
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conjunctivitis, deafness, menorrhagia, and rickets. In 1855, Bertin wrote a book on 
compressed air therapy and even constructed his own hyperbaric chamber.
Compressed air therapy was first introduced into the USA by JL Corning in 
1871. In 1876, Kelly treated a patient in a “Compressed Air Bath Apparatus” having 
two locking plates operated from outside to seal pressures. In 1877, French surgeon 
Fontaine developed the first mobile hyperbaric operating theater. The high ambient 
pressure was claimed to facilitate the reduction of hernias and provide relief for 
patients with lung diseases. Over the next 3 months, 27 surgeries were successfully 
performed within this mobile hyperbaric chamber (Figure 5). Spurred by the 
results, Fontaine ventured to erect a mammoth hyperbaric surgical amphitheater 
to accommodate 300 patients in one sitting. This did not see the light of day as 
Fontaine died from an accident at the Pneumatic Institute to become the first physi-
cian to be martyred in the history of hyperbaric medicine [4].
In 1885, C Theodore Williams published his “Lectures on the Compressed Air Bath 
and its Uses in the Treatment of Disease” in the British Medical Journal, extolling the 
use of atmospheric air under different degrees of atmospheric pressure to treat dis-
eases. He remarked that this mode of therapy was among the most important advances 
in modern medicine and expressed astonishment at its being ignored in England [5].
Back in the USA, during the closing days of the World War I, Kansas-bavsed 
physician Orval J Cunningham built a hyperbaric chamber in 1921 at Lawrence, 
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swept North America. Noticing that people in the valley fared better than those 
living in the mountains, Cunningham theorized that atmospheric pressure or 
barometric factors were responsible for the higher mortality rates in those residing 
at higher elevations. He observed remarkable improvements in patients treated with 
HBO, especially those who were cyanotic and comatose. In 1923, heat from open 
gas burners warming the chambers in winter scorched the insulation and started a 
fire, but all patients were safely evacuated. In another incident, a mechanical failure 
caused a complete loss of pressure within the chamber and all patients died. This 
did not, however, deter Cunningham’s enthusiasm for hyperbaric air. He went on to 
treat diseases such as syphilis, hypertension, diabetes mellitus, and cancer, believ-
ing that anaerobic infections played a role in the etiology of all these afflictions. In 
1928, with the financial backing of Henry H. Timken, a roller bearing manufacturer 
and tycoon, Cunningham built the largest hyperbaric chamber in the world along 
the shores of Lake Erie in Cleveland, Ohio, at a cost of 1 million dollars. This “Steel 
Ball Hospital” or “Cunningham’s Sanitarium” was a five-story high steel sphere, 
64 ft in diameter with 60 rooms and weighing 900 tons. Each floor of this structure 
had 12 rooms, with all the amenities of a good hotel (Figures 6 and 7). The growing 
popularity of Cunningham’s treatments prompted the Bureau of Investigation of the 
American Medical Association (AMA) to request the doctor to validate his claims 
Figure 5. 
Fontaine’s mobile hyperbaric operation theater.
Figure 6. 
Cunningham’s hyperbaric hotel—outside and inside view.
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regarding the effectiveness of hyperbaric therapy. Cunningham refused to share the 
details or cooperate with the AMA, leading to his being labeled a quack and a fraud. 
The chamber was dismantled in 1937 and sold for scrap during World War II [6].
3. A historical account of decompression sickness and its treatment
In 1840, Charles Pasley, charged with the recovery of the sunken warship HMS 
Royal George, commented that, of those who made frequent dives, “not a man 
escaped the repeated attacks of rheumatism and cold.” In 1841, Trigger, a French 
mining engineer, used a pressure chamber to deliver workers to the bottom of the 
river to extract coal. In 1845, he reported that some of his miners complained of 
joint pains and nervous disorders after surfacing. The first recorded death from 
“caisson disease” (which later came to be known as decompression illness (DCI) or 
acute decompression sickness) occurred in 1859 during the building of the Royal 
Albert Bridge, a railway bridge in England spanning the River Tamar from Saltash 
to Plymouth. Several workers were taken ill after emerging from deep underground 
after long hours of work under high atmospheric pressure conditions. In 1871, 
during the construction of the Eads Bridge in St. Louis, 352 compressed air workers, 
including Alphonse Jaminet, the physician in charge, were employed. Thirty work-
ers developed serious conditions with 12 ending fatally. Jaminet himself suffered 
decompression sickness, and his personal description was the first such recorded. It 
was in 1873 that Andrew Smith first utilized the term “caisson disease” to describe 
110 cases of decompression sickness that occurred during construction of the 
Brooklyn Bridge. The project employed 600 compressed air workers, and recom-
pression treatment was not available on site. In 1882, during the Hudson tunnel 
construction in New York, every fourth worker died of bends until a recompression 
chamber was installed to treat the condition. Only three workers died of bends over 
the next 18 months.
Paul Bert, a French professor of physiology and a student of Claude Bernard, 
is considered the father of pressure physiology (Figure 8). In 1878, while working 
closely with Dr. Alphonse Gal, the first doctor to actually dive in order to study 
Figure 7. 
Cunningham’s hyperbaric hotel—exterior and interior views.
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how the body reacted underwater, Bert studied Gal’s reports on divers who became 
symptomatic or died while surfacing. He conducted a series of dog experiments, 
exposing them to 7–9¾ atmospheres and subjecting them to rapid decompres-
sion. A majority of them died and exhibited grossly distended bodies with their 
right heart chambers filled with gas. When decompression was done at slowly 
over 1–2 hours after exposure to similar pressures, none of the dogs succumbed. 
Applying Dalton’s and Henry’s gas laws, Bert concluded that too rapid a decom-
pression induced a pathophysiologic insult secondary to supersaturation of body 
tissues with nitrogen, causing the formation of nitrogen bubbles. He also went on to 
suggest that divers stop halfway to the surface to allow for slow decompression after 
a deep dive—what is now known as deep stops. Bert was also the first to describe 
oxygen toxicity at pressures in excess of 1.75 ATA. This adverse effect on the central 
nervous system came to be known as the “Paul Bert effect” [7, 8].
In 1908, Scottish physiologist John Scott Haldane conducted experiments at the 
Lister Institute of Preventive Medicine in London assisted by Lieutenant Guybon 
Damant of the Royal Navy, an expert diver and amateur scientist, and a physiologist 
Edwin Arthur Boycott. A herd of 85 goats was assembled, and the researchers put 
groups of up to eight goats inside compression chambers for specific periods of time. 
Pressures were then normalized before releasing the animals into the institute’s yard 
for observation. These studies confirmed that those goats decompressed by stages 
did not exhibit signs of the bends (Figure 9). Haldane then introduced the concept 
of half times—the time required for a particular tissue to become half saturated with 
Figure 8. 
Dr. Paul Bert (1883–1886).
Figure 9. 
Bends in the foreleg of a goat after experiments performed by physiologist Haldane [9].
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a gas—and recommended staged decompression, especially at shallower depths. He 
prepared detailed practical dive tables for the Royal Navy to prevent acute decom-
pression sickness. These guidelines remained the foundation of all diving operations 
until 1956 [10]. Heinrich Drager was the first to explore the use of pressurized 
oxygen in decompression sickness (Figure 10). His protocols were put into practice 
by Behnke and Shaw, who used HBOT for treating decompression sickness in the 
late 1930s. They replaced oxygen in place of compressed air, and their work resulted 
in the use of the first nitrogen-oxygen mixtures and hyperbaric treatment being 
tailored to the severity of the injury [11]. In 1939, the US Navy began treating divers 
suffering decompression sickness with hyperbaric oxygen therapy. After World War 
II, the US military conducted extensive research in HBOT, and this expanded the 
existing knowledge about survivable pressures and popularized HBOT in the late 
1950s and early 1960s. In the 1980s, Paul Harch began an in-depth study of brain 
decompression illness (DCI) and evaluated divers with this disorder. He con-
cluded that it was not residual gas that was being treated but ischemic brain injury.  
He went on to develop individualized treatment protocols for over 50 different chronic 
neurological disorders. Harch is considered to be the foremost authority in the use of 
HBOT and SPECT brain blood flow imaging in neurology [12–14]. In 1990, former 
microbiology professor Igor Gamow invented and patented the Gamow Bag that 
provided mountaineers with a mobile and effective method to treat high-altitude 
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foot pump, to simulate a descent to 7000 ft (Figure 11). In 1992, Harch treated the 
first delayed decompression sickness, which led to the treating of “dementia pugilis-
tica” in boxers and cerebral palsy and autism in children [15].
4. Treating diseases with HBO
In 1937, Brazilians Ozorio de Almeida and Costa pioneered the use of HBOT 
in treating leprosy [16]. In the 1950s, Ite Boerema, a cardiac surgeon from the 
Netherlands, conceived the idea of “flooding” the body’s tissues with extra oxygen. 
Working with the help of the Royal Dutch Navy, Boerema conducted a series of 
animal experiments and operations within a hyperbaric oxygen chamber (Figure 12). 
These went off without a hitch and led to the installation of a large operating hyper-
baric chamber at the University of Amsterdam. Many children with congenital heart 
diseases like tetralogy of Fallot, transposition of great vessels, and pulmonic stenosis 
were operated in this facility with great success. Boerema mooted the concept of “Life 
without blood” using HBO, when dissolved oxygen sufficed to meet the entire body’s 
oxygen needs without the need for red cells or hemoglobin. Boerema is credited with 
being the father of modern-day hyperbaric medicine [17].
In 1955–1956, I Churchill-Davidson evaluated clinical trials on HBOT as a 
potentiator for radiation therapy in cancer patients at St. Thomas Hospital in 
London [18]. Public interest in hyperbaric oxygen therapy started to grow in the 
1960s after publicity about its use in treating President John F Kennedy’s sick 
infant. In 1961, a colleague of Boerema, W. H. Brummelkamp, published a paper on 
inhibition of anaerobic infections by HBOT [19]. In 1962, Smith and Sharp reported 
the enormous benefits of HBO in carbon monoxide poisoning. They recommended 
that all those having a verified carboxyhemoglobin level above 25% needed imme-
diate HBOT at 3 ATA for 90 minutes, followed by two or three more sessions for 
full recovery, making HBO very cost-effective [20]. Global interest in HBOT was 
rekindled by this finding, resulting in hyperbaric units being installed at many 
centers like Duke University, New York Mount Sinai Hospital, Presbyterian Hospital 
and Edgeworth Hospital in Chicago, Good Samaritan in Los Angeles, St. Barnabas 
Hospital in New Jersey, Harvard Children’s Hospital, and St. Luke’s Hospital in 
Milwaukee. In 1965, Perrins from the UK demonstrated the effectiveness of HBOT 
Figure 12. 
Dr. Boerema with children operated by him.
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Air or gas embolism
Carbon monoxide poisoning; cyanide poisoning; smoke inhalation
Clostridial myositis and myonecrosis (gas gangrene)
Crush injuries, compartment syndromes, and other acute traumatic peripheral ischemias
Decompression sickness
Enhancement of healing in selected problem wounds
Exceptional blood loss anemia
Intracranial abscess
Necrotizing soft tissue infections
Refractory osteomyelitis
Skin flaps and grafts (compromised)
Delayed radiation injury (soft tissue and bony necrosis)
Thermal burns
Table 1. 
UHMS- and FDA-approved indications for hyperbaric oxygen therapy.
in osteomyelitis [21]. In 1966, Saltzman and coworkers from the USA proved the 
effectiveness of HBOT in stroke patients [22].
In 1970, Boschetty and Cernoch of Czechoslovakia conducted a trial of HBOT for 
multiple sclerosis. In their series 15 out of 26 patients with multiple sclerosis showed 
improvement after HBOT at 2 atmospheres [23]. In 1971, Lamm of West Germany 
used HBOT for treatment of sudden deafness. It was shown that HBOT shortens 
the course of healing in high-pitch perception dysacusis by upregulating constitu-
tive nitric oxide synthase in the substructure of the cochlea [24]. In 1973, Thurston 
pioneered studies that showed lower mortality figures in patients with myocardial 
infarction treated with HBO. HBOT was shown to improve oxygen supply to the 
threatened heart and reduce the volume of infarct size and other major adverse out-
comes [25]. In 1972, Richard A Neubauer set up the Ocean Hyperbaric Neurologic 
Center in Lauderdale-by-the-Sea exclusively for HBOT in the management of vari-
ous central nervous system disorders. He mooted the concept of “idling” neurons 
capable of surviving for years or even decades after the original injury. He claimed 
that these injured neurons could be re-activated with HBOT and that the greater the 
number of idling neurons, the better would be the patient’s response to HBOT [26]. 
Neubauer was also the co-founder and executive director of the American College 
of Hyperbaric Medicine. After his death in 2007 at the age of 83, his clinical research 
center in Florida was renamed the Neubauer Hyperbaric Neurologic Center. In 1976, 
Hollbach and Wasserman determined that 1.5 ATA (atmospheres absolute) maxi-
mizes oxygen content and glucose metabolism in the brain [27].
In 1985, RE Marx and his colleagues observed that the rate of osteoradionecrosis was 
30%/patient in patients treated with penicillin alone while rates in those treated with 
HBO was only 5% [28]. In 1987, Jain successfully treated patients with paralytic stroke 
using HBOT [29, 30]. In 2002, a US Army study confirmed that HBOT repairs white 
matter damage in children with cerebral palsy. In 2005, Stoller of the USA treated the 
first case of a child with fetal alcohol syndrome using HBOT and with good outcome 
[31]. In 2006, Thom of the USA discovered that HBO causes stem cell mobilization [32]. 
In 2010, Godman discovered that HBOT activated 8101 genes, resulting in reduction of 
inflammation and increase in growth in body tissues [33, 34]. In 2011, Stoller treated 
the first retired National Football League (NFL) player for chronic traumatic encepha-
lopathy [35]. In 2012, Harch and his colleagues demonstrated that blast-induced post-
concussion syndrome and post-traumatic stress disorders responded to HBOT [15].
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The UHMS and FDA approved HBOT for treatment of conditions like autism, 
stroke, air embolism, ischemic limbs, split-thickness skin graft acceptance, failed 
grafts, flap survival and salvage, wound reepithelialization, acute thermal burns, 
etc. (Table 1) [36, 37].
Many patients do not respond to aggressive acid-suppressing medications. 
HBOT has a beneficial effect in patients with blunt duodenal trauma, duodenal 
ulcers, and indomethacin-/radiation-induced gastritis. This salubrious effect is 
mediated by decreased production of oxidative stress markers like tumor necrosis 
factor-alpha, interleukin-1beta, neopterin, myeloperoxidase, and malondialdehyde. 
HBOT is seen to improve the acid-neutralizing function of the stomach, normalize 
gastric motility, reduce the duodenum acidification, decrease edema, and improve 
the blood flow both in human and equine studies [38, 39]. These effects were also 
seen in cases of inflammatory bowel diseases like Crohn’s [40].
5. Landmark academic events in HBOT
In September 1961, the First International Congress on the clinical applica-
tions of hyperbaric oxygen was held in Amsterdam. The Second International 
Conference on HBO was held in Glasgow in September 1964, with detailed delib-
erations on various aspects of HBOT. In November 1965, the Third International 
Congress on HBOT was organized at the Duke University at Durham, North 
Carolina. The Fourth and Fifth International Congresses were held in Sapporo, 
Japan, and Vancouver, respectively, in 1969 and 1973. The University of 
Aberdeen, Scotland, hosted the sixth conference in August 1977. The subsequent 
International Congress was held in Moscow in 1981 and is an annual event 
thereafter. The deliberations during these academic forums threw fresh light on 
the basic physiology, oxygen toxicity, and therapeutic applications of HBO in 
human disease.
The Undersea Medical Society (it added hyperbaric to its name in 1986), an 
organization made up largely of naval and ex-navy physicians, was founded in 
1967 in the USA. It reviewed the indiscriminate and inappropriate use of the 
HBO chamber for a variety of medical conditions by practitioners searching for a 
“cure-all” therapy, tarnishing the credibility of hyperbaric medicine. This non-
profit organization, now known as the Undersea and Hyperbaric Medical Society 
(UHMS), set up a Committee on Hyperbaric Oxygen Therapy in the 1970s to 
systematically review all the available scientific evidence for HBOT and formulate 
absolute indications for HBOT. This was accepted by insurance providers, includ-
ing Medicare. The UHMS is committed to providing, promoting, developing, 
and raising the quality of care across the spectrum in scientific communication, 
life sciences, and clinical practices of hyperbaric medicine by promoting high 
standards of patient care and operational safety. It offers accreditation and certifi-
cate of competency and credibility and has over 2500 members in 50 countries. 
UHMS also awards board certification in Undersea and Hyperbaric Medicine 
through the American Board of Emergency Medicine (ABEM), the American 
Board of Preventive Medicine (ABPM), and fellowship training in Undersea and 
Hyperbaric Medicine.
In 1980, Dr. Richard A. Neubauer and Dr. William S. Maxfield formed the 
American College of Hyperbaric Medicine (ACHM) to foster the ethical advance-
ment and expansion of hyperbaric medicine. The International Society of 
Hyperbaric Medicine was founded in 1988.
Hyperbaric medicine was approved by the American Board of Medical 
Specialties as a sub-specialty of emergency and preventative medicine in 2000.
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Air or gas embolism
Carbon monoxide poisoning; cyanide poisoning; smoke inhalation
Clostridial myositis and myonecrosis (gas gangrene)
Crush injuries, compartment syndromes, and other acute traumatic peripheral ischemias
Decompression sickness
Enhancement of healing in selected problem wounds
Exceptional blood loss anemia
Intracranial abscess
Necrotizing soft tissue infections
Refractory osteomyelitis
Skin flaps and grafts (compromised)
Delayed radiation injury (soft tissue and bony necrosis)
Thermal burns
Table 1. 
UHMS- and FDA-approved indications for hyperbaric oxygen therapy.
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6. Developments in HBOT chambers
In 1860, the first hyperbaric chamber in the North American continent was 
constructed in Oshawa, Ontario, Canada. A year later, a neurologist, James Leonard 
Corning, built the first hyperbaric chamber in the USA in New York. This chamber 
was used to treat “nervous and related disorders.” The first decompression chamber 
was invented by the Italian engineer Alberto Gianni in 1916 [39, 40]. In 1928, the 
Harvard Medical School built a hyperbaric chamber for medical research. Among 
the largest HBOT chambers is the 22 ton 32 ft wide 14 ft wide one at the Utah Valley 
Regional Medical Center, USA.
In modern times, many traditional hard-shell hyperbaric chambers and soft-
shell, portable hyperbaric chambers (Figures 13–18) are manufactured by several 
companies and available in every major city. The latest chambers must comply 
with NFPA-992012 Edition Chapter 14 Code in the USA and European 1997 CEN 
pressure vessels 97/23E standards as well as the 1998 ECHM recommendations 
for safety. The newer chambers feature hingeless pressure-sealed doors, antifric-
tion bearings, antibacterial leather upholstery, and high-quality resin fiber loop 
mattresses and pillows that dissipate heat and moisture generated by the body 
during therapy. The newer low-pressure monoplace chambers are portable and less 
Figure 13. 
The evolution of hyperbaric chambers.
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expensive. Operating between 1.2 and 1.3 ATA pressures, they are eminently suited 
for use in homes and spas and also find use to improve results after plastic surgery.
The earliest documentation of therapeutic use of HBOT in animals was in 1998. 
The Veterinary Hyperbaric Medicine Society was formed in 2006. Veterinary-
specific hyperbaric chambers are available.











6. Developments in HBOT chambers
In 1860, the first hyperbaric chamber in the North American continent was 
constructed in Oshawa, Ontario, Canada. A year later, a neurologist, James Leonard 
Corning, built the first hyperbaric chamber in the USA in New York. This chamber 
was used to treat “nervous and related disorders.” The first decompression chamber 
was invented by the Italian engineer Alberto Gianni in 1916 [39, 40]. In 1928, the 
Harvard Medical School built a hyperbaric chamber for medical research. Among 
the largest HBOT chambers is the 22 ton 32 ft wide 14 ft wide one at the Utah Valley 
Regional Medical Center, USA.
In modern times, many traditional hard-shell hyperbaric chambers and soft-
shell, portable hyperbaric chambers (Figures 13–18) are manufactured by several 
companies and available in every major city. The latest chambers must comply 
with NFPA-992012 Edition Chapter 14 Code in the USA and European 1997 CEN 
pressure vessels 97/23E standards as well as the 1998 ECHM recommendations 
for safety. The newer chambers feature hingeless pressure-sealed doors, antifric-
tion bearings, antibacterial leather upholstery, and high-quality resin fiber loop 
mattresses and pillows that dissipate heat and moisture generated by the body 
during therapy. The newer low-pressure monoplace chambers are portable and less 
Figure 13. 
The evolution of hyperbaric chambers.
77
Historical Aspects of Hyperbaric Physiology and Medicine
DOI: http://dx.doi.org/10.5772/intechopen.85216
expensive. Operating between 1.2 and 1.3 ATA pressures, they are eminently suited 
for use in homes and spas and also find use to improve results after plastic surgery.
The earliest documentation of therapeutic use of HBOT in animals was in 1998. 
The Veterinary Hyperbaric Medicine Society was formed in 2006. Veterinary-
specific hyperbaric chambers are available.











7. Current status of HBOT
HBOT was called the Cinderella of modern medicine since it was not taught 
in medical schools and had no pharmaceutical companies to nurture and protect 
it. Over the course of time, it has shed the label of being a mysterious therapy 
and become a major tool in the armamentarium of clinicians either as a primary 
or adjunctive therapy for a spectrum of diseases. Stroke, cancer, heart disease, 
and chronic lung disease account for almost 60% of the total number of deaths. 
Hypoxia is a significant component of the pathology of these conditions, and this 
leads to metabolic acidosis, organ dysfunction, and death. Conventional oxygen 
therapy may not have desired results, when HBOT yields remarkable clinical 
improvement. HBOT prevents 75 percent of all major amputations that would 
 otherwise be necessary for diabetic wounds and a 450% increase in complete 
recovery in patients with traumatic brain injury receiving HBOT vs. standard 
intensive care. Newer application of HBOT is in emergency care for  resuscitation 
in cases of acute blood loss, near drowning, hanging and poisoning, and 
 cardiorespiratory arrest.
Athletic associations like the NFL employ hyperbaric oxygen therapy as part 
of the recovery regimen for its athletes, and some players own their own HBOT 
chambers. Joe Namath experienced remarkable recovery from the head injuries 
he sustained during his career, leading him to be part of an FDA-approved study 
of HBOT at the Joe Namath Neurological Center of the Jupiter Medical Center in 
Florida. Ace swimmer Michael Phelps and football stars Maurice Jones-Drew and 
James Harrison have endorsed the benefits of HBOT, along with professional boxers 
like Evander Holyfield [41].
8. Conclusions
With the utilization of isotopic tracers, magnetic resonance imaging (MRI), 
and single-photon emission computed tomography (SPECT), HBOT is getting 
evidence-based recognition. Various conditions like brain injuries, stroke, and 
neurological diseases with poor prognosis are now amenable to improved outcomes 
with the application of HBOT. There are more than 500 hyperbaric facilities 
Figure 18. 
Hyperbaric operation suite. (Image courtesy: CONE Health Wound Care and Hyperbaric Center, 
Greensboro, North Carolina, USA).
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in the USA alone. Much research remains to be done regarding the efficacy of 
HBO2 therapy to develop treatment plans for those in extremes of age. The use of 
 hyperbaric  medicine to treat wounds in the foot or in the brain is a divine gift, and 
great advances in this field are on the horizon. The future of healthcare is here!
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